Parkinson's disease, including avohilmo

G6_PARKINSON_INCLAVO

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — G20 1 out of 7 registries used, show all original rules.	4402
4. Check minimum number of events None	4402
5. Include endpoints G6_PARKINSON	7936
6. Filter based on genotype QC (FinnGen only)	6955

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF5

NAME	G6_PARKINSON_INCLAVO
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	G6_PARKINSON
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	G20
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Parkinson's disease, including avohilmo based on the number of shared cases.

Similar with more cases:

Any event in hilmo or specialist outpatient

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6955	2776	4179
Unadjusted period prevalence (%)	1.54	0.99	1.92
Median age at first event (years)	70.29	69.30	70.95

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7111: Matched controls
71106

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H02AA02

ATC

fludrocortisone; oral

14.4

321.0

294

213

G04BD12

ATC

mirabegron; oral

3.0

309.9

1694

6649

R25.1

ICD-10 Finland

Tremor, unspecified

19.1

307.7

1462

950

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

2626.0

307.7

1540

N04AA02

ATC

biperiden; systemic

19.2

307.7

605

342

N04BC04

ATC

ropinirole; oral

155.4

307.7

1308

103

N87

ICPC

Parkinsonism

320.8

307.7

2303

106

N04BD01

ATC

selegiline; oral

552.9

307.7

2185

N04BX04

ATC

opicapone; oral

+∞

307.7

313

N04BX02

ATC

entacapone; oral

5266.0

307.7

501

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

56.4

307.7

261

G23.9

ICD-10 Finland

Degenerative disease of basal ganglia, unspecified

76.0

307.7

214

N04BC09

ATC

rotigotine; transdermal

159.3

307.7

462

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

569.9

307.7

5728

513

N04BC05

ATC

pramipexole; oral

11.3

307.7

2370

3011

N06DA03

ATC

rivastigmine; oral, transdermal

7.1

307.7

1384

2338

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

76.6

307.7

201

193

Kela drug reimbursment

Rasagiline

+∞

307.7

847

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

10138.1

307.7

899

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

45.2

307.7

844

211

N05AH04

ATC

quetiapine; oral

4.2

307.7

2027

6232

AA5EN

NOMESCO Finland

Brain reseptor or transprot protein distribution isotope imaging

51.5

307.7

287

N04BB01

ATC

amantadine; oral

15.3

307.7

466

325

N04BD02

ATC

rasagiline; oral

3182.1

307.7

1126

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

+∞

307.7

5754

N03AE01

ATC

clonazepam; systemic

4.9

307.7

861

1957

AAG20

NOMESCO Finland

Stereotactic intracranial implantation of electrodes

172.0

307.7

265

G20

ICD-10 Finland

Parkinson disease

+∞

307.7

6399

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.6

284.3

1071

3342

G23.1

ICD-10 Finland

Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]

62.1

263.6

146

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

4.1

259.6

783

2090

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

26.2

251.6

174

C07AA05

ATC

propranolol; systemic

2.7

231.2

1613

7084

G25.0

ICD-10 Finland

Essential tremor

5.1

225.4

494

1021

R53

ICD-10 Finland

Malaise and fatigue

2.3

217.3

2341

12480

I95.1

ICD-10 Finland

Orthostatic hypotension

3.7

214.7

730

2111

L28

ICPC

Limited function/disability (L)

2.3

213.4

2200

11496

A28

ICPC

Limited function/disability NOS

2.2

198.5

2225

11977

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

12.1

193.4

195

165

G25.2

ICD-10 Finland

Other specified forms of tremor

12.6

192.9

190

155

AA1AD

NOMESCO Finland

CT of head and brain

2.1

183.3

2948

18121

G21.8

ICD-10 Finland

Other secondary parkinsonism

41.4

182.5

110

R4130

NOMESCO Finland

Speech therapy

4.9

177.4

408

876

N05AH02

ATC

clozapine; systemic

10.1

176.3

201

204

N19

ICPC

Speech disorder

7.0

170.2

264

390

N04BC06

ATC

cabergoline; oral

21.4

165.9

124

F20.9

ICD-10 Finland

Schizophrenia, unspecified

7.1

165.5

254

371

XF606

NOMESCO Finland

Ortostatic test

8.3

161.4

214

264

N05AH03

ATC

olanzapine; systemic

3.6

161.2

556

1615

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.1

158.8

2181

12509

XA800

NOMESCO Finland

Neuropsychological investigation

4.1

155.4

443

1125

F02.39

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

1546.1

152.6

148

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.8

151.3

842

3245

A06AD11

ATC

lactulose; oral

2.2

150.2

1700

9031

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

145.3

2872

18561

N28

ICPC

Limited function/disability (N)

5.1

145.3

312

631

SPAT1229

SPAT

Assessment of need for aid

2.5

133.7

912

3880

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

7.1

131.0

200

290

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

4.3

127.4

344

837

G23.8

ICD-10 Finland

Other specified degenerative diseases of basal ganglia

41.0

127.3

3320A

ICD-9 Finland

Parkinson's disease, Paralysis agitans

+∞

122.2

117

N29

ICPC

Neurological sympt/complt other

4.7

117.1

281

623

SPAT1216

SPAT

Assessment of functional ability

2.0

116.2

1605

9065

N05AF05

ATC

zuclopenthixol; systemic

8.8

114.6

144

166

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.7

114.1

677

2681

N03AG01

ATC

valproic acid; systemic, rectal

3.0

112.5

516

1779

N05AF03

ATC

chlorprothixene; systemic

4.8

110.6

257

555

29599

ICD-8 Finland

Schizophrenia, Unspecified type

12.0

109.9

111

G90.3

ICD-10 Finland

Multi-system degeneration

46.1

108.7

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

5.8

108.3

202

359

N04BC02

ATC

pergolide; oral

275.2

106.2

108

G02CB01

ATC

bromocriptine; systemic

8.2

105.7

141

175

D21

ICPC

Swallowing problem

4.7

105.6

248

540

N05BA04

ATC

oxazepam; oral

1.8

105.5

2026

12686

R1250

NOMESCO Finland

Evaluation of functional capability

4.0

104.5

306

790

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

102.6

1464

8319

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

3.7

102.4

341

963

N06AX11

ATC

mirtazapine; oral

1.8

101.8

2484

16659

R5110, ,

SPAT

2.3

101.6

916

4381

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.5

101.5

696

2951

N05AX12

ATC

aripiprazole; systemic

4.9

99.5

222

463

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

15.6

98.3

N05AC02

ATC

thioridazine; oral

5.0

97.9

212

431

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

96.4

2283

15129

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

96.2

1500

8756

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.2

95.6

880

4239

N04AA01

ATC

trihexyphenidyl; oral

54.4

94.8

N06AB10

ATC

escitalopram; oral

2.0

90.8

1164

6348

SPAT1234

SPAT

Support of social functional capacity

2.5

90.2

608

2552

U04

ICPC

Incontinence urine

2.4

89.7

668

2935

P72

ICPC

Schizophrenia

5.5

88.9

175

327

N05AA02

ATC

levomepromazine; systemic

3.2

87.9

373

1226

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

87.2

1389

8135

R4130, ,

SPAT

10.6

86.6

S01.0

ICD-10 Finland

Open wound of scalp

2.2

86.3

807

3903

A04

ICPC

Weakness/tiredness general

1.9

86.2

1321

7639

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.7

85.9

286

807

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

8.0

85.1

115

145

29580

ICD-8 Finland

Schizophrenia, Other

9.6

84.5

104

F02.30

ICD-10 Finland

Dementia in Parkinson's disease without additional symptoms

828.2

83.7

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.4

82.9

602

2613

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.9

81.3

394

1397

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.1

80.4

872

4461

N05AN01

ATC

lithium; oral

4.7

80.3

188

408

N05AX08

ATC

risperidone; systemic

2.1

80.3

822

4114

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.2

79.8

713

3381

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.4

79.3

561

2405

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

6.5

78.6

129

202

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

2.5

78.1

518

2155

N05AA01

ATC

chlorpromazine; systemic, rectal

5.6

76.4

147

269

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.6

76.0

258

737

N99

ICPC

Neurological disease other

4.6

74.0

177

391

N05BA06

ATC

lorazepam; systemic, sublingual

2.4

72.6

509

2171

N30.0

ICD-10 Finland

Acute cystitis

1.8

71.9

1255

7514

29570

ICD-8 Finland

Schizophrenia, Schizo-affective type

13.6

70.7

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

70.1

1395

8674

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

69.1

694

3439

R35

ICD-10 Finland

Polyuria

2.1

65.5

694

3507

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

64.8

2353

16997

F02.32

ICD-10 Finland

Dementia in Parkinson's disease other additional symptoms, mainly hallucinations

+∞

64.7

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.5

64.6

445

1880

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.1

64.5

276

911

R47.1

ICD-10 Finland

Dysarthria and anarthria

4.7

63.3

148

321

N08

ICPC

Abnormal involuntary movements

9.6

63.0

F0230, G20,

ICD-10 Finland

623.7

62.9

SPAT1297

SPAT

Other function in accordance with speech therapy nomenclature

9.3

62.7

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

62.7

1220

7513

F20.5

ICD-10 Finland

Residual schizophrenia

7.7

62.3

114

N05AB03

ATC

perphenazine; systemic, rectal

3.0

61.9

277

938

R44.1

ICD-10 Finland

Visual hallucinations

6.7

61.4

149

S72.0

ICD-10 Finland

Fracture of neck of femur

2.3

60.1

483

2184

188

Kela drug reimbursment

Psychosis requiring demanding treatment

7.1

59.6

129

F0232, G20,

ICD-10 Finland

+∞

59.4

2959E

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN AKUUTTI VAIHE]

12.4

58.9

YX8AD

NOMESCO Finland

Stereotactic CT examination for dose design of radiotherapy

19.7

58.1

29530

ICD-8 Finland

Schizophrenia, Paranoid type

8.4

57.8

K59.0

ICD-10 Finland

Constipation

2.2

57.4

544

2629

R4110, ,

SPAT

1.8

55.5

1034

6269

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.0

55.0

244

822

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.3

54.1

430

1933

F20

ICD-10 Finland

Schizophrenia

8.0

54.0

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

6.3

53.7

144

Z2445

NOMESCO Finland

Psychologist

3.1

53.5

223

724

UDQ42

NOMESCO Finland

Endoscopic assessment of swallowing function

8.1

53.3

W19

ICD-10 Finland

Unspecified fall

1.8

51.7

800

4584

N06AB04

ATC

citalopram; systemic

1.6

50.8

1383

9247

29510

ICD-8 Finland

Schizophrenia, Hebephrenic type

9.9

48.9

2959C

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]

9.4

48.9

N03AX12

ATC

[U] gabapentin; oral

1.7

47.8

1129

7274

R41.0

ICD-10 Finland

Disorientation, unspecified

2.4

47.4

347

1504

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.5

47.3

315

1309

R1420, ,

SPAT

6.0

47.0

140

F20.0

ICD-10 Finland

Paranoid schizophrenia

7.0

46.9

102

G23.2

ICD-10 Finland

Multiple system atrophy, parkinsonian type [MSA-P]

164.4

46.9

P20

ICPC

Memory disturbance

1.6

45.9

1401

9597

R1260

NOMESCO Finland

Evaluation of communicative skills

3.3

45.6

175

541

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

3.3

44.9

170

521

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

4.1

44.8

123

303

G24.9

ICD-10 Finland

Dystonia, unspecified

10.1

44.2

R1250, ,

SPAT

2.6

43.9

266

1056

AXX01

NOMESCO Finland

Memory assessment

4.4

43.5

108

246

R60.0

ICD-10 Finland

Localized oedema

1.6

43.5

1052

6806

AA5QN, ,

NOMESCO Finland

115.8

42.8

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

4.1

42.6

117

288

R32

ICD-10 Finland

Unspecified urinary incontinence

2.5

41.3

259

1046

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

4.4

41.3

104

240

S06.0

ICD-10 Finland

Concussion

1.8

41.1

737

4396

G04BD08

ATC

solifenacin; oral

1.9

40.8

583

3247

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

2.7

40.1

221

837

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.6

40.0

133

375

P29

ICPC

Psychological sympt/compl other

2.3

39.9

304

1341

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.3

39.8

302

1330

130

Kela drug reimbursment

Malignant tumour

0.4

39.7

204

4974

F20.10

ICD-10 Finland

Raise schizophrenia continuously

8.2

39.3

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.0

39.2

440

2260

R13

ICD-10 Finland

Dysphagia

1.8

38.8

577

3254

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.0

38.8

169

564

J01EA01

ATC

trimethoprim; systemic

1.5

38.4

1695

12484

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

7.2

38.1

S70.0

ICD-10 Finland

Contusion of hip

2.1

38.1

356

1708

N86

ICPC

Multiple sclerosis

6.5

37.8

F02.34

ICD-10 Finland

Dementia in Parkinson's disease, other additional symptoms of mixed type

+∞

37.5

M48.0

ICD-10 Finland

Spinal stenosis

1.6

37.4

1051

7029

D12

ICPC

Constipation

2.2

37.2

342

1630

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.4

37.1

132

389

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

37.0

1875

14160

2957A

ICD-9 Finland

Schizophrenic psychoses, Schizo-affective type

9.1

36.8

N04BC07

ATC

apomorphine; parenteral

+∞

36.5

F06.0

ICD-10 Finland

Organic hallucinosis

8.2

36.3

R2110

NOMESCO Finland

Giving the first information

2.0

36.2

382

1917

H50.52

ICD-10 Finland

Exophoria

4.6

35.8

187

SPAT1053

SPAT

Memory test

1.5

35.8

1361

9712

R23

ICPC

Voice symptom/complaint

3.1

35.6

154

512

SPAT1254

SPAT

Administration of medicine

1.5

35.4

1137

7826

2953E

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN AKUUTTI]

8.3

35.0

29560

ICD-8 Finland

Residual schizophrenia

12.1

35.0

M03BX01

ATC

baclofen; systemic

3.1

34.9

148

486

R42

ICD-10 Finland

Dizziness and giddiness

1.4

34.2

1746

13168

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

5.8

34.0

108

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

34.0

583

3427

Z02.4

ICD-10 Finland

Examination for driving licence

0.7

33.9

1486

19685

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

11.8

33.4

2959A

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,TARKEMMIN MÄÄRITTELEMÄT]

9.0

33.3

R4120, ,

SPAT

3.2

33.2

129

402

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.6

33.2

879

5787

N05BA01

ATC

diazepam; systemic, rectal

1.6

33.1

863

5659

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.5

33.0

205

825

SPAT1301

SPAT

No procedures

1.4

32.7

2196

17342

SPAT1240

SPAT

Therapeutic discussion

1.9

32.6

443

2424

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

4.5

32.6

181

N06AX21

ATC

duloxetine; oral

1.7

32.6

671

4147

N04BC01

ATC

bromocriptine; oral

37.5

32.4

N06AX16

ATC

venlafaxine; oral

1.7

32.4

684

4255

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.5

32.4

111

320

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.0

32.1

359

1840

J01CA08

ATC

pivmecillinam; oral

1.4

32.1

2108

16574

M54.5

ICD-10 Finland

Low back pain

1.4

31.8

2112

16633

R1430, ,

SPAT

3.2

31.2

123

387

ZYC01

NOMESCO Finland

Remote contact by phone

1.9

31.1

379

2002

N03AX09

ATC

lamotrigine; oral

2.5

30.9

203

838

P99

ICPC

Psychological disorders other

2.9

30.7

144

501

R55

ICD-10 Finland

Syncope and collapse

1.6

30.7

906

6107

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

30.3

470

2679

R5130, ,

SPAT

5.0

30.2

128

G04BD11

ATC

fesoterodine; oral

2.2

30.1

252

1156

C01CA01

ATC

etilefrine; systemic

4.0

29.4

205

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

29.3

502

2948

TAB00

NOMESCO Finland

Lumbar puncture

2.2

29.2

262

1236

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.4

29.2

201

848

34200

ICD-8 Finland

Paralysis agitans, Parkinsonismus

+∞

29.2

F20.1

ICD-10 Finland

Hebephrenic schizophrenia

11.6

29.1

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.0

29.0

128

431

N06AX26

ATC

vortioxetine; oral

1.9

28.9

351

1850

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

5.1

28.9

118

S01.8

ICD-10 Finland

Open wound of other parts of head

2.9

28.9

139

491

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.9

28.9

134

464

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

5.2

28.7

115

N02BE01

ATC

paracetamol; systemic, rectal

1.5

28.5

6037

56379

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

8.6

28.4

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.2

28.3

250

1173

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

28.1

449

2583

A29

ICPC

General symptom/complaint other

1.5

27.8

987

6914

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.2

27.6

239

1112

XKD00

NOMESCO Finland

Uroflowmetry

1.4

27.5

1445

10894

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.6

27.5

252

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

27.3

840

5704

F05.9

ICD-10 Finland

Delirium, unspecified

2.2

27.2

226

1035

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

27.0

652

4189

N02AA05

ATC

oxycodone; systemic

1.4

26.9

1510

11505

SPAT1244

SPAT

Occupational therapy

3.4

26.8

290

H50.31

ICD-10 Finland

Intermittent exotropia

5.0

26.7

115

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

26.7

696

4555

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.9

26.6

318

1668

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

5.6

26.6

29500

ICD-8 Finland

Schizophrenia, Simple type

8.2

26.5

S01.41

ICD-10 Finland

Open wound in the temple-jaw region

3.4

26.3

279

F02.3

ICD-10 Finland

Dementia in Parkinson disease

+∞

26.1

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

26.0

583

3675

I95.9

ICD-10 Finland

Hypotension, unspecified

2.5

26.0

160

641

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

6.1

25.8

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

25.5

1207

8920

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.8

25.4

209

N05CD07

ATC

temazepam; oral

1.5

25.2

924

6504

Z29

ICPC

Social problem NOS

2.6

25.1

146

570

F02.31

ICD-10 Finland

Dementia in Parkinson's disease other additional symptoms, mainly paranoidism

+∞

25.0

AAW01

NOMESCO Finland

Implantation of intracranial stimulation device

58.2

25.0

L03

ICPC

Low back symptom/complaint

1.4

25.0

1663

13007

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.9

24.9

302

1592

Z75.5

ICD-10 Finland

Holiday relief care

3.1

24.9

105

345

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

7.8

24.6

SPAT1167

SPAT

Insertion of urinary catheter

1.9

24.6

305

1619

R26

ICD-10 Finland

Abnormalities of gait and mobility

6.1

24.5

R33

ICD-10 Finland

Retention of urine

1.5

24.5

750

5085

N05AD01

ATC

haloperidol; systemic

2.0

24.4

252

1255

N04BA07

ATC

foslevodopa and decarboxylase inhibitor; parenteral

+∞

24.0

A03FA01

ATC

metoclopramide; systemic, rectal

0.7

23.9

750

10712

G72.8

ICD-10 Finland

Other specified myopathies

2.5

23.9

151

613

G25.1

ICD-10 Finland

Drug-induced tremor

7.4

23.7

N06AX03

ATC

mianserin; oral

1.9

23.6

321

1756

G04BD09

ATC

trospium; oral

2.2

23.5

203

944

WYA20

NOMESCO Finland

Home visit

2.3

23.5

184

822

G04BD04

ATC

oxybutynin; oral, transdermal

1.7

23.5

400

2343

2951C

ICD-9 Finland

Schizophrenic psychoses, Disorganised type[HEBEFREENISTYYPPINEN SKITSOFRENIA,KROONINEN]

8.2

23.5

H02AB02

ATC

dexamethasone; systemic

0.5

23.4

295

5254

N04BX01

ATC

tolcapone; oral

+∞

22.9

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.8

22.7

113

407

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

3.3

22.7

260

K11.72

ICD-10 Finland

Xerostomia

19.0

22.5

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.7

22.5

119

443

R1100, ,

SPAT

2.8

22.4

111

399

U07

ICPC

Urine symptom/complaint other

1.6

22.4

614

4058

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.2

22.3

180

815

G04CA02

ATC

tamsulosin; oral

1.3

22.0

2200

18182

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

22.0

491

3091

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

4.3

22.0

131

ZY000

NOMESCO Finland

Hospital inpatient

3.8

22.0

170

F0234, G20,

ICD-10 Finland

+∞

21.9

Z50.5

ICD-10 Finland

Speech therapy

3.0

21.9

323

L84

ICD-10 Finland

Corns and callosities

2.0

21.8

248

1280

AA1AA

NOMESCO Finland

Head X-ray examination

3.3

21.8

242

K08.3

ICD-10 Finland

Retained dental root

1.6

21.7

541

3498

29999

ICD-8 Finland

Unspecified psychosis

5.2

21.7

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.0

21.6

315

F20.34

ICD-10 Finland

Undifferentiated schizophrenia with partial recurrence

8.7

21.5

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.4

21.4

143

596

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

6.0

21.2

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

2.6

21.1

121

469

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

21.1

1081

8075

JX1LA

NOMESCO Finland

Kinetic X-ray of alimentary tract with pictures

8.5

21.0

C10AX09

ATC

ezetimibe; oral

0.7

20.9

637

9177

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

20.8

630

4256

N31.8

ICD-10 Finland

Other neuromuscular dysfunction of bladder

4.1

20.7

137

W06

ICD-10 Finland

Fall involving bed

3.0

20.6

297

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.1

20.5

272

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.7

20.4

106

391

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

5.9

20.4

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

5.4

20.4

S01.9

ICD-10 Finland

Open wound of head, part unspecified

2.4

20.3

138

581

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

2.6

20.2

112

427

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

20.2

981

7255

AA400

NOMESCO Finland

Electroconvulsive therapy

4.2

20.2

127

K02.1

ICD-10 Finland

Caries of dentine

1.3

20.2

3085

26814

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

2.4

20.1

140

595

G04BD07

ATC

tolterodine; oral

1.7

19.9

373

2245

P03

ICPC

Feeling depressed

1.7

19.8

338

1981

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.9

19.8

151

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

4.2

19.7

125

S00.0

ICD-10 Finland

Superficial injury of scalp

2.1

19.7

187

904

UKC02

NOMESCO Finland

Cystoscopy

1.3

19.7

1338

10447

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

19.6

594

4011

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

7.7

19.5

N02BF01

ATC

gabapentin; oral

1.5

19.5

619

4223

SPAT1304

SPAT

Counselling and guidance related to ageing

1.5

19.3

635

4361

M04AA01

ATC

allopurinol; systemic

0.7

19.3

606

8688

C03CA01

ATC

furosemide; systemic

1.3

19.2

2700

23188

M41.9

ICD-10 Finland

Scoliosis, unspecified

2.8

19.2

331

F20.8

ICD-10 Finland

Other schizophrenia

5.9

19.1

SPAT1235

SPAT

Mental health, emotional support

4.6

19.1

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.1

19.1

179

862

IGY99, ,

SPAT

3.9

19.0

146

EBA00

NOMESCO Finland

Extraction of tooth

1.3

18.9

2064

17177

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.1

18.8

182

887

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.1

18.7

173

829

R44.3

ICD-10 Finland

Hallucinations, unspecified

3.7

18.6

153

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.5

18.6

114

458

G04CB01

ATC

finasteride; oral

1.4

18.5

1077

8198

U05

ICPC

Urination problems other

1.6

18.4

420

2659

2953C

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN]

6.4

18.3

R63.4

ICD-10 Finland

Abnormal weight loss

1.8

18.3

304

1768

J01MA02

ATC

ciprofloxacin; systemic

1.3

18.3

2688

23168

IGY02, ,

SPAT

3.3

18.1

199

A06AX04

ATC

linaclotide; oral

5.0

18.0

F31

ICD-10 Finland

Bipolar affective disorder

3.8

18.0

143

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.8

18.0

259

1445

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.9

18.0

219

1158

U02

ICPC

Urinary frequency/urgency

1.4

17.8

888

6591

N03AA03

ATC

primidone; oral

5.3

17.7

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.3

17.5

1856

ICB03, ,

SPAT

7.8

17.4

F25.0

ICD-10 Finland

Schizoaffective disorder, manic type

7.8

17.4

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

3.1

17.3

230

K03.66

ICD-10 Finland

Tooth plaque

1.6

17.3

458

3001

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

17.3

2827

24615

SPAT1172

SPAT

Guidance concerning hydration

1.9

17.2

203

1062

F22.0

ICD-10 Finland

Delusional disorder

2.6

17.1

100

393

ICB01, ,

SPAT

3.6

17.0

158

N05AE04

ATC

ziprasidone; systemic

6.9

17.0

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

16.9

2048

17218

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.4

16.9

691

4950

N06AB06

ATC

sertraline; oral

1.5

16.7

498

3351

OAB73, ,

SPAT

4.0

16.6

115

XKC03

NOMESCO Finland

Water cystometry

1.9

16.6

199

1047

R30.1

ICD-10 Finland

Vesical tenesmus

2.1

16.5

157

761

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

4.0

16.4

116

G35

ICD-10 Finland

Multiple sclerosis

3.0

16.3

228

F06.2

ICD-10 Finland

Organic delusional [schizophrenia-like] disorder

6.3

16.3

E86

ICD-10 Finland

Volume depletion

1.9

16.2

211

1140

C10AA07

ATC

rosuvastatin; oral

0.8

16.2

1514

18361

IFA99, ,

SPAT

6.8

16.1

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.1

16.1

209

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

15.9

933

7103

SPAT1050

SPAT

Extensive neurological examination

2.1

15.8

149

719

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.4

15.8

1743

29540

ICD-8 Finland

Acute schizophrenia episode

5.7

15.8

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

3.2

15.8

196

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

15.8

499

3399

R5210, ,

SPAT

6.9

15.7

IGV01

NOMESCO Finland

Psychiatric network contact

4.3

15.7

AAG99

NOMESCO Finland

Other stereotactic intracranial operation

+∞

15.6

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.4

15.5

922

7029

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

5.6

15.5

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.3

15.5

1622

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

6.2

15.4

S22.3

ICD-10 Finland

Fracture of rib

1.5

15.4

475

3219

AA1BG, ,

SPAT

2.3

15.4

110

475

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.4

15.4

103

432

RF120, ,

NOMESCO Finland

2.7

15.3

297

H02AB06

ATC

prednisolone; systemic

0.8

15.3

2376

27247

P73

ICPC

Affective psychosis

5.9

15.2

IHZ05, ,

SPAT

2.3

15.2

110

478

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

15.1

833

6276

C01CA17

ATC

midodrine; oral

45.1

15.0

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

3.4

15.0

162

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.4

14.9

1638

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

14.9

221

1245

P01

ICPC

Feeling anxious/nervous/tense

1.6

14.9

320

1996

M41.4

ICD-10 Finland

Neuromuscular scoliosis

31.7

14.8

N17

ICPC

Vertigo/dizziness

1.4

14.7

856

6501

L29

ICPC

Musculoskeletal sympt/complt other

1.5

14.7

543

3812

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.4

14.7

825

6230

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

2.8

14.6

265

R5140, ,

SPAT

2.3

14.6

103

442

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

14.6

682

4998

R2130, ,

SPAT

2.4

14.5

394

A08

ICPC

Swelling

1.5

14.5

414

2757

N31.0

ICD-10 Finland

Uninhibited neuropathic bladder, not elsewhere classified

4.3

14.5

3010

Kela drug reimbursment

Midodrine

36.1

14.4

ZY010

NOMESCO Finland

Hospital outpatient

1.8

14.4

200

1105

L17

ICPC

Foot/toe symptom/complaint

1.2

14.3

1878

15875

N05AX13

ATC

paliperidone; systemic

5.7

14.1

WYA20, ,

SPAT

2.8

14.1

248

G25

ICD-10 Finland

Other extrapyramidal and movement disorders

6.4

14.1

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.3

14.1

975

7601

N05AB02

ATC

fluphenazine; systemic

3.3

14.0

154

N05AL01

ATC

sulpiride; systemic

2.4

14.0

413

ZXH01

NOMESCO Finland

Procedure performed within operation theatre

6.7

14.0

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.7

14.0

436

6283

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.2

14.0

115

527

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.4

13.9

614

4456

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.7

13.8

280

1722

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

13.7

707

5267

F25.2

ICD-10 Finland

Schizoaffective disorder, mixed type

10.4

13.7

Z3226

NOMESCO Finland

Physiotherapist

1.3

13.7

1083

8598

F20.01

ICD-10 Finland

Paranoid schizophrenia periodically with gradual deterioration

6.5

13.6

F023, G20,

ICD-10 Finland

+∞

13.5

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

4.8

13.5

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

13.4

1337

10931

N31.1

ICD-10 Finland

Reflex neuropathic bladder, not elsewhere classified

3.1

13.4

174

F20.02

ICD-10 Finland

Paranoid schizophrenia stable periodically

6.3

13.3

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

3.4

13.3

135

N03AF02

ATC

oxcarbazepine; oral

1.9

13.2

176

960

TKC22

NOMESCO Finland

Catheterisation instruction

1.8

13.2

182

1004

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

3.1

13.2

181

A01

ICPC

Pain general/multiple sites

1.4

13.2

615

4506

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

4.0

13.1

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

3.8

13.1

103

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

15.0

13.1

RF420, ,

NOMESCO Finland

2.4

13.0

347

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.7

13.0

234

1395

F25

ICD-10 Finland

Schizoaffective disorders

13.0

12.9

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

5.6

12.9

T08

ICPC

Weight loss

2.1

12.8

123

600

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

2.0

12.7

126

622

L01BC06

ATC

capecitabine; oral

0.4

12.7

1589

S20.2

ICD-10 Finland

Contusion of thorax

1.6

12.6

313

2024

SPAT1262

SPAT

Handing over of treatment supplies

1.3

12.5

1178

9553

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.7

12.5

102

G23.3

ICD-10 Finland

Multiple system atrophy, cerebellar type [MSA-C]

130.2

12.4

Y94.0

ICD-10 Finland

Accident at home

2.0

12.4

136

696

3AX01, ,

NOMESCO Finland

4.8

12.4

P98

ICPC

Psychosis NOS/other

4.4

12.3

S00.8

ICD-10 Finland

Superficial injury of other parts of head

2.1

12.3

111

529

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.3

12.3

132

M40.1

ICD-10 Finland

Other secondary kyphosis

5.3

12.3

SCA02

NOMESCO Finland

Preventive oral health care

1.5

12.3

428

2973

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.7

12.3

235

1425

N05AD03

ATC

melperone; systemic

2.2

12.2

102

471

F05.8

ICD-10 Finland

Other delirium

2.5

12.2

291

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

2.8

12.2

211

F20.19

ICD-10 Finland

Hebefren schizophrenia UNS

9.6

12.2

N04AB02

ATC

orphenadrine (chloride); systemic

37.6

12.2

R26.2

ICD-10 Finland

Difficulty in walking, not elsewhere classified

2.2

12.2

104

485

TKC20, ,

SPAT

2.8

12.2

217

S72.1

ICD-10 Finland

Pertrochanteric fracture

1.8

12.1

192

1105

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

2.9

12.1

185

Z43.5

ICD-10 Finland

Attention to cystostomy

2.6

12.1

252

SPAT1260

SPAT

Consultation of another employee

1.3

12.0

1062

8547

TJD10

NOMESCO Finland

Insertion of other tube into stomach or duodenum

5.7

11.9

IAB01, ,

SPAT

4.3

11.9

H53.2

ICD-10 Finland

Diplopia

1.7

11.9

205

1209

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.4

11.7

610

4547

N30

ICD-10 Finland

Cystitis

1.5

11.7

375

2560

ZXY02

NOMESCO Finland

Neuropsychologist

3.9

11.7

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.7

11.6

199

1171

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

11.6

1231

10120

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

11.6

1387

11561

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.2

11.6

436

SPAT1243

SPAT

Psychiatric/psychological examination

2.4

11.6

317

Z11

ICPC

Compliance/being ill problem

2.8

11.5

201

Z50.1

ICD-10 Finland

Other physical therapy

1.5

11.5

321

2129

F0231, G20,

ICD-10 Finland

+∞

11.5

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

3.0

11.4

164

K88

ICPC

Postural hypotension

2.3

11.4

362

G24.8

ICD-10 Finland

Other dystonia

4.8

11.4

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

11.4

1141

9318

L76

ICPC

Fracture: other

1.7

11.3

209

1255

XQ858, ,

SPAT

2.8

11.3

192

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

2.0

11.3

118

595

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

11.3

1029

8308

IAA01, ,

SPAT

3.9

11.3

2956C

ICD-9 Finland

Schizophrenic psychoses, Residual schizophrenia[RESIDUAALINEN SKITSOFRENIA,KROONINEN]

10.5

11.2

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

2.9

11.1

183

359

Kela drug reimbursment

Mirabegroni

2.8

11.1

194

S01

ICD-10 Finland

Open wound of head

2.3

11.1

367

N06DA02

ATC

donepezil; oral

1.4

11.1

528

3881

SPAT1360

SPAT

Extensive global examination

1.4

11.1

440

3134

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.7

11.0

223

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.3

11.0

712

5490

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.4

10.9

628

4756

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

10.9

892

7099

97010

ICD-8 Finland

Adverse effect of psychotherapeutics, Tranquillisers

3.8

10.9

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

1.9

10.9

139

750

XQ855, ,

SPAT

2.2

10.9

383

K07

ICPC

Swollen ankles/oedema

1.5

10.9

356

2444

R4110

NOMESCO Finland

Physiotherapy

1.2

10.8

1689

14465

IHZ04, ,

SPAT

2.7

10.8

214

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

1.9

10.8

130

688

G04CB02

ATC

dutasteride; oral

1.3

10.8

672

5151

N87

ICD-10 Finland

Dysplasia of cervix uteri

28.0

10.7

Z75.0

ICD-10 Finland

Medical services not available in home

4.4

10.7

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

10.6

3382

30880

IBC97

NOMESCO Finland

Other psychiatric aptitude assessment

60.1

10.6

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

4.1

10.6

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

2.2

10.6

388

N02CA01

ATC

dihydroergotamine; nasal, systemic

3.7

10.6

R43.0

ICD-10 Finland

Anosmia

2.9

10.6

172

K56.2

ICD-10 Finland

Volvulus

2.6

10.5

229

WF002

NOMESCO Finland

Radical radiotherapy

0.6

10.5

180

2955

M54

ICD-10 Finland

Dorsalgia

1.4

10.4

546

4074

M79.6

ICD-10 Finland

Pain in limb

1.2

10.4

2485

22125

G22

ICD-10 Finland

Parkinsonism in diseases classified elsewhere

110.2

10.4

A04AA02

ATC

granisetron; systemic, transdermal

0.6

10.4

154

2627

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.8

10.4

155

878

TJD20

NOMESCO Finland

Change of gastrostomy tube

3.4

10.4

106

G21

ICD-10 Finland

Secondary parkinsonism

32.6

10.3

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

10.3

624

4762

SFA10

NOMESCO Finland

One-surface restoration

1.2

10.3

2844

25642

R25.8

ICD-10 Finland

Other and unspecified abnormal involuntary movements

4.0

10.2

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.5

10.2

302

2033

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.8

10.1

148

833

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

10.1

549

4121

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

3.3

10.1

113

L02

ICPC

Back symptom/complaint

1.4

10.1

448

3256

S97

ICPC

Chronic ulcer skin

1.4

10.0

456

3325

OAB43, ,

SPAT

0.6

10.0

233

3567

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.9

10.0

150

NFB10

NOMESCO Finland

Primary partial prosthetic replacement of hip joint not using cement, other or unspecified

3.4

10.0

SPAT1263

SPAT

Sampling

1.2

10.0

2469

22035

G81.9

ICD-10 Finland

Hemiplegia, unspecified

2.3

9.9

296

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

9.9

256

1673

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

0.3

9.9

870

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

7.6

9.9

Z60.8

ICD-10 Finland

Other problems related to social environment

3.5

9.9

SPAT1252

SPAT

Overall medication plan or its review

1.4

9.8

468

3440

G24.5

ICD-10 Finland

Blepharospasm

4.5

9.8

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

4.7

9.7

S20

ICPC

Corn/callosity

1.8

9.7

147

836

M43.1

ICD-10 Finland

Spondylolisthesis

1.6

9.7

210

1315

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.3

9.7

618

4754

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.4

9.6

257

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

1.8

9.6

144

817

SPAT1042

SPAT

Guidance concerning balance maintenance

2.9

9.6

148

WX110

NOMESCO Finland

Infiltration anesthesia

1.2

9.6

4014

37336

29820

ICD-8 Finland

Other psychoses, Reactive confusion

5.3

9.6

2962E

ICD-9 Finland

Affective psychoses, Major depressive disorder, single episode[PSYCH.BIPOLARIS MANICA,VAIKEA-ASTE,PSYKOOT PIIRTEIT]

9.1

9.5

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.4

9.5

389

2787

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

2.5

9.5

241

F20.08

ICD-10 Finland

Paranoid schizophrenia other definite

7.1

9.5

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.4

9.4

272

SPAT1139

SPAT

Nutrition survey

1.6

9.4

210

1326

S62.3

ICD-10 Finland

Fracture of other metacarpal bone

1.8

9.4

126

692

IGP01

NOMESCO Finland

Psychiatric family contact

3.9

9.4

AA5FN, ,

NOMESCO Finland

+∞

9.4

F02.33

ICD-10 Finland

Dementia in Parkinson's disease other additional symptoms, mainly depression

+∞

9.4

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

9.4

3792

35153

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

4.4

9.3

H51.1

ICD-10 Finland

Convergence insufficiency and excess

4.9

9.3

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

3.2

9.3

114

SPAT1101

SPAT

Orthostatic test

1.5

9.3

329

2296

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.4

9.3

256

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

9.2

1790

15614

R5599

NOMESCO Finland

Other rehabilitation service

1.7

9.2

152

887

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

2.3

9.2

275

AA052, ,

NOMESCO Finland

13.7

9.2

N05CF01

ATC

zopiclone; oral

1.2

9.2

2071

18309

D64.9

ICD-10 Finland

Anaemia, unspecified

1.3

9.2

841

6786

L02BB04

ATC

enzalutamide; oral

0.2

9.1

446

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.1

9.1

379

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.3

9.1

961

7882

R49.03

ICD-10 Finland

Atrophic dysphonia

2.0

9.1

480

IEY19, ,

SPAT

5.0

9.1

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.3

9.1

815

6560

2988A

ICD-9 Finland

Other nonorganic psychoses, Other and unspecified reactive psychosis

4.6

9.0

U29

ICPC

Urinary symptom/complaint other

1.6

9.0

202

1277

S00

ICD-10 Finland

Superficial injury of head

2.8

9.0

148

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

0.5

9.0

1413

WX212

NOMESCO Finland

Femoral plexus blockade

1.7

9.0

169

1022

SPAT1125

SPAT

Stoma care and guidance

1.8

9.0

129

723

G04CA01

ATC

alfuzosin; oral

1.2

9.0

987

8129

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.3

9.0

101

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

0.3

9.0

749

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

9.0

1827

16002

N05AF01

ATC

flupentixol; systemic

2.0

8.9

429

M10.9

ICD-10 Finland

Gout, unspecified

0.7

8.9

285

4088

L75

ICPC

Fracture: femur

1.9

8.9

103

540

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

1.5

8.9

249

1658

31099

ICD-8 Finland

Borderline mental retardation, Other and unspecified

7.9

8.8

SPAT1241

SPAT

Extensive assessment of psychosocial situation

3.0

8.8

123

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.2

8.8

1336

11386

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.4

8.8

238

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.3

8.7

754

6038

RF410, ,

NOMESCO Finland

2.2

8.7

314

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

8.7

1860

16353

K44

ICD-10 Finland

Diaphragmatic hernia

2.5

8.7

221

OAA80, ,

SPAT

0.4

8.7

1130

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.4

8.7

355

2545

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

0.7

8.7

287

4091

F61

ICD-10 Finland

Mixed and other personality disorders

4.2

8.6

S01.3

ICD-10 Finland

Open wound of ear

2.1

8.6

388

H02.3

ICD-10 Finland

Blepharochalasis

1.4

8.6

392

2862

R3110

NOMESCO Finland

Psychosocial training

3.9

8.6

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.5

8.6

225

1477

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

0.5

8.5

1395

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.4

8.5

339

2419

AAG10

NOMESCO Finland

Stereotactic intracranial destruction of nucleus or nerve tract

27.5

8.5

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

3.4

8.5

G21.2

ICD-10 Finland

Secondary parkinsonism due to other external agents

20.0

8.5

SPAT1104

SPAT

Monitoring of emergency patient

1.4

8.5

388

2836

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

8.5

717

5728

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

0.6

8.4

148

2414

R49.08

ICD-10 Finland

Other specified dysphonia

1.8

8.4

113

622

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.6

8.4

166

1019

U71

ICPC

Cystitis/urinary infection other

1.4

8.4

337

2409

A10BK03

ATC

empagliflozin; oral

0.7

8.4

392

5270

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

0.4

8.4

1113

ZYC02, ,

SPAT

3.5

8.3

WX290

NOMESCO Finland

Other blockage of nerve

1.2

8.3

2037

18097

R39.1

ICD-10 Finland

Other difficulties with micturition

1.5

8.3

215

1406

P28

ICPC

Limited function/disability (P)

2.8

8.3

144

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.6

8.3

202

1305

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.3

8.3

716

5736

IHZ07, ,

SPAT

2.9

8.3

128

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

1.6

8.2

165

1017

R5599, ,

SPAT

3.2

8.2

EBA30

NOMESCO Finland

Extraction of root of tooth

1.4

8.2

354

2563

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.4

8.2

322

2293

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.5

8.1

281

1954

AA1AM

NOMESCO Finland

Short MRI examination of brain with 3 Tesla magnet

4.7

8.1

N03AX16

ATC

[U] pregabalin

1.2

8.1

1316

11279

29630

ICD-8 Finland

Affective psychoses, Manic-depressive psychosis, circular type

6.8

8.0

SPAT1293

SPAT

Other function in accordance with rehabilitation guidance nomenclature

2.7

8.0

158

RF433, ,

NOMESCO Finland

8.9

8.0

A04AA55

ATC

palonosetron, combinations; systemic

0.4

8.0

908

N06AG02

ATC

moclobemide; oral

1.5

8.0

217

1437

L03AA02

ATC

filgrastim; parenteral

0.4

8.0

1063

A27

ICPC

Fear of other disease NOS

1.4

7.9

300

2121

2954A

ICD-9 Finland

Schizophrenic psychoses, Acute schizophrenic episode

4.3

7.9

K90

ICPC

Stroke/cerebrovascular accident

1.5

7.9

214

1415

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

0.2

7.9

367

N05AA03

ATC

promazine; systemic

4.4

7.9

L12

ICPC

Hand/finger symptom/complaint

1.2

7.9

855

7031

RF214, ,

NOMESCO Finland

6.6

7.9

S01.40

ICD-10 Finland

Open wound on the cheek

2.6

7.8

166

NB6AA

NOMESCO Finland

Humerus X-ray examination

1.7

7.8

141

846

R74

ICPC

Upper respiratory infection acute

0.8

7.8

818

9905

2956E

ICD-9 Finland

Schizophrenic psychoses, Residual schizophrenia[RESIDUAALINEN SKITSOFRENIA,KROONINEN AKUUTTI VAIHE]

10.8

7.8

S72.9

ICD-10 Finland

Fracture of femur, part unspecified

2.7

7.8

155

N05AC01

ATC

periciazine; systemic

3.2

7.8

29520

ICD-8 Finland

Schizophrenia, Catatonic type

6.9

7.8

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.7

7.7

122

705

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.7

7.7

149

910

N05AC04

ATC

pipotiazine; systemic

45.0

7.7

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.2

7.7

1314

11309

ZYC01, ,

SPAT

1.3

7.7

476

3648

NF3BA

NOMESCO Finland

Femur extensive X-ray examination

3.3

7.6

Z73.6

ICD-10 Finland

Limitation of activities due to disability

2.3

7.6

235

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

1.7

7.6

134

799

3339X

ICD-9 Finland

Other extrapyramidal disease and abnormal movement disorders, Other and unspecified extrapyramidal diseases and abnormal movement disorders

18.4

7.6

F0280, G318,

ICD-10 Finland

18.4

7.6

N04AC01

ATC

benzatropine; systemic

18.4

7.6

S09.9

ICD-10 Finland

Unspecified injury of head

1.9

7.6

527

J01DB01

ATC

cefalexin; oral

1.2

7.6

5088

48590

29899

ICD-8 Finland

Other psychoses, Reactive psychosis, unspecified

6.7

7.6

F20.29

ICD-10 Finland

Catat schizophrenia UNS

25.0

7.6

RF432, ,

NOMESCO Finland

25.0

7.6

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

1.7

7.6

129

763

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

0.2

7.5

501

N06AB05

ATC

paroxetine; oral

1.5

7.5

234

1593

S32.1

ICD-10 Finland

Fracture of sacrum

2.4

7.5

193

S63.1

ICD-10 Finland

Dislocation of finger

1.9

7.5

485

30180

ICD-8 Finland

Personality disorders, Immatura

3.1

7.5

SPAT1281

SPAT

Other administrative function

1.3

7.5

414

3117

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

1.7

7.5

125

735

P76

ICPC

Depressive disorder

1.5

7.5

195

1280

IEV99, ,

SPAT

7.1

7.5

N80

ICPC

Head injury other

1.8

7.5

112

639

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.5

7.4

241

1656

A46

ICD-10 Finland

Erysipelas

1.2

7.4

990

8320

N05BE01

ATC

buspirone; oral

1.7

7.4

130

775

M41.5

ICD-10 Finland

Other secondary scoliosis

3.4

7.4

R27.0

ICD-10 Finland

Ataxia, unspecified

2.9

7.4

109

R09.3

ICD-10 Finland

Abnormal sputum

2.0

7.3

344

183

Kela drug reimbursment

Lamotrigin and topiramate

2.7

7.3

137

N03AF01

ATC

carbamazepine; oral, rectal

1.4

7.3

283

2011

WW500

NOMESCO Finland

Blood transfusion

0.6

7.3

1697

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

1.7

7.3

114

658

N04C02, ,

ATC

+∞

7.3

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

0.6

7.3

136

2181

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.6

7.3

180

1169

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.3

7.3

724

5897

S28

ICPC

Limited function/disability (S)

2.2

7.3

266

E87.6

ICD-10 Finland

Hypokalaemia

1.5

7.2

211

1419

F25.1

ICD-10 Finland

Schizoaffective disorder, depressive type

6.2

7.2

G31.0

ICD-10 Finland

Circumscribed brain atrophy

2.5

7.2

179

A99

ICPC

Disease/condition unspecnature/site

1.3

7.2

599

4775

F0289, G318,

ICD-10 Finland

30.0

7.1

F34.1

ICD-10 Finland

Dysthymia

1.7

7.1

130

783

RF210, ,

NOMESCO Finland

1.7

7.1

136

829

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

3.4

7.1

N05AE03

ATC

sertindole; oral

6.6

7.1

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

3.3

7.1

29830

ICD-8 Finland

Other psychoses, Acute paranoid reaction

3.8

7.1

L86

ICPC

Back syndrome with radiating pain

1.4

7.1

324

2371

N05AX16

ATC

brexpiprazole; oral

6.0

7.1

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

7.1

2188

19748

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.3

7.0

452

3482

N06AX12

ATC

bupropion; oral

1.6

7.0

168

1083

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.6

7.0

152

A03FA02

ATC

cisapride; oral, rectal

1.3

7.0

451

3476

G24.3

ICD-10 Finland

Spasmodic torticollis

2.4

7.0

188

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.6

7.0

166

1068

30088

ICD-8 Finland

Neuroses, Other

2.8

7.0

118

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

3.1

7.0

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.3

7.0

456

3522

C08CA01

ATC

amlodipine; oral

0.9

7.0

2356

25817

R11

ICD-10 Finland

Nausea and vomiting

1.3

6.9

468

3630

S42.0

ICD-10 Finland

Fracture of clavicle

1.6

6.9

142

882

N05BA12

ATC

alprazolam; oral

1.3

6.9

484

3772

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.3

6.9

220

S03.0

ICD-10 Finland

Dislocation of jaw

3.0

6.9

Z03

ICPC

Housing/neighbourhood problem

2.4

6.9

177

F31.2

ICD-10 Finland

Bipolar affective disorder, current episode manic with psychotic symptoms

5.4

6.9

M70.6

ICD-10 Finland

Trochanteric bursitis

1.2

6.9

706

5769

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.5

6.9

230

1592

F0029, G308,

ICD-10 Finland

3.6

6.9

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.6

6.8

143

893

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.3

6.8

215

A10BJ06

ATC

semaglutide; parenteral

0.6

6.8

102

1727

SFE01

NOMESCO Finland

Carriage renovation

3.3

6.8

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.4

6.8

277

1988

S22

ICPC

Nail symptom/complaint

1.3

6.8

375

2827

R03AK03

ATC

[U] fenoterol and ipratropium bromide

0.7

6.8

199

2898

L03AA13

ATC

pegfilgrastim; parenteral

0.6

6.8

1484

R01AD59

ATC

mometasone, combinations; nasal

0.5

6.8

1290

U01

ICPC

Dysuria/painful urination

1.4

6.8

364

2732

JN4BD

NOMESCO Finland

Extensive body CT

0.8

6.8

420

5419

L99

ICPC

Musculoskeletal disease other

1.7

6.7

120

719

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.4

6.7

243

1707

AA3AD

NOMESCO Finland

CT of face

2.2

6.7

236

I10

ICD-10 Finland

Essential (primary) hypertension

0.9

6.7

4109

43338

WYA30, ,

SPAT

2.6

6.7

138

F20.12

ICD-10 Finland

Hebefren schizophrenia stable periodically

22.5

6.7

3321A

ICD-9 Finland

Parkinson's disease, Secondary Parkinsonism

22.5

6.7

WF004

NOMESCO Finland

Palliative radiotherapy

0.4

6.6

905

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

6.6

632

5123

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

3.0

6.6

F03

ICD-10 Finland

Unspecified dementia

1.3

6.6

354

2657

IFA01, ,

SPAT

5.9

6.6

SFA30

NOMESCO Finland

Three-surface restoration

1.1

6.6

2173

19679

NF3AA

NOMESCO Finland

Femur X-ray examination

1.6

6.6

141

886

S80.0

ICD-10 Finland

Contusion of knee

1.4

6.6

318

2348

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

1.5

6.6

181

1204

N06AX22

ATC

agomelatine; oral

2.0

6.6

352

S03.20

ICD-10 Finland

Dental dislocation

3.2

6.5

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

3.3

6.5

NAG53

NOMESCO Finland

Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea

4.2

6.5

IAZ99

NOMESCO Finland

Other psychiatric consultation

4.2

6.5

F06.32

ICD-10 Finland

Organic depression

3.8

6.5

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.7

6.5

116

696

J01.0

ICD-10 Finland

Acute maxillary sinusitis

0.8

6.5

642

7830

SPAT1251

SPAT

Organisation of medication

1.5

6.5

218

1510

SFA20

NOMESCO Finland

Two-surface restoration

1.1

6.5

2870

26505

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

1.6

6.5

131

812

ZX120, ,

SPAT

1.8

6.5

496

30099

ICD-8 Finland

Neuroses, Unspecified neurosis

3.6

6.5

Z43.1

ICD-10 Finland

Attention to gastrostomy

3.9

6.4

G21.4

ICD-10 Finland

Vascular parkinsonism

69.9

6.4

T93

ICPC

Lipid disorder

0.7

6.4

241

3356

B03XA02

ATC

darbepoetin alfa; parenteral

0.4

6.4

851

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

0.8

6.4

466

5889

SPAT1138

SPAT

Guidance concerning bowel function

1.8

6.4

506

SPAT1246

SPAT

Screening of depression or other psychiatric problem

1.7

6.4

115

693

F02.09*G31.0

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

4.1

6.3

ZXE22

NOMESCO Finland

Procedure duration at least 4 but less than 5 hours

8.1

6.3

F20.20

ICD-10 Finland

Catatonic schizophrenia continuously

8.1

6.3

R40.2

ICD-10 Finland

Coma, unspecified

2.1

6.3

282

Z10.1

ICD-10 Finland

Routine general health check-up of inhabitants of institutions

5.5

6.3

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

3.4

6.3

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

0.7

6.3

170

2512

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.4

6.3

267

1932

F23.3

ICD-10 Finland

Other acute predominantly delusional psychotic disorders

3.2

6.3

SPAT1266

SPAT

Separate instruction to prepare for procedure

1.6

6.3

146

937

G21.3

ICD-10 Finland

Postencephalitic parkinsonism

+∞

6.2

N04AA03

ATC

metixene; oral

26.7

6.2

K02

ICD-10 Finland

Dental caries

1.4

6.2

290

2130

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

1.5

6.2

165

1090

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

1.9

6.2

373

N18

ICPC

Paralysis/weakness

1.6

6.2

130

813

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.3

6.2

205

S09.8

ICD-10 Finland

Other specified injuries of head

2.3

6.2

180

N06AA04

ATC

clomipramine; systemic

1.9

6.2

402

UGC12

NOMESCO Finland

Flexible bronchoscopy

0.7

6.1

313

4152

R40.0

ICD-10 Finland

Somnolence

3.2

6.1

WVA20, ,

SPAT

1.5

6.1

192

1313

F30.0

ICD-10 Finland

Hypomania

5.7

6.1

SPAT1307

SPAT

Psychosocial counselling and guidance

1.6

6.1

139

888

R07.3

ICD-10 Finland

Other chest pain

1.3

6.1

574

4646

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

0.9

6.1

1357

15362

N06AA06

ATC

trimipramine; systemic

1.7

6.1

112

679

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

2.0

6.1

300

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.8

6.1

965

11232

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.2

6.0

1713

15330

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.1

6.0

2252

20540

R4160, ,

SPAT

2.8

6.0

105

SPAT1127

SPAT

Enema

2.0

6.0

287

Z93.5

ICD-10 Finland

Cystostomy status

2.9

6.0

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.1

6.0

1892

17056

R03BB04

ATC

tiotropium bromide; inhalant

0.8

6.0

452

5690

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3026008) Bacteria identified in Urine by Culture

3139

22004

1.76

113.42

4.4

3.6

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3006

22239

1.61

78.93

2.6

2.3

258.46

215.68

u/l

1.51

2860

20896

(3021960) Folate [Moles/volume] in Serum or Plasma

2920

21543

1.60

76.96

1.9

1.8

18.83

19.97

nmol/l

3.97

2563

18047

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

112

156

7.28

76.06

15.5

18.2

1439.70

1325.75

nmol/l

0.31

106

150

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

115

176

6.62

71.60

2.1

1.2

124.22

135.36

nmol/l

0.23

131

(3009466) Valproate [Moles/volume] in Serum or Plasma

258

779

3.40

69.76

6.8

4.2

373.07

340.79

umol/l

2.96

237

665

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

102

148

6.98

66.76

11.4

13.5

846.20

757.59

nmol/l

0.78

142

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3900

31489

1.53

64.43

2.5

2.3

89.48

93.81

pmol/l

8.39

2387

16866

(3031040) Bacteria [#/volume] in Urine by Automated count

4937

42334

1.54

58.66

6.9

5.4

3001.07

2138.60

e6/l

0.30

699

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4280

35736

1.50

56.63

6.2

7.6

1.21

mmol/l

4.53

3735

30653

(3024666) Lithium [Moles/volume] in Serum or Plasma

135

6.66

55.91

14.0

12.8

0.67

0.64

mmol/l

0.40

124

(3019309) Folate [Moles/volume] in Red Blood Cells

1971

14061

1.56

55.54

1.9

1.8

1176.77

1156.55

nmol/l

0.43

1527

10469

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3857

32149

1.44

47.23

5.8

6.9

1.21

mmol/l

0.76

3555

29499

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1836

13319

1.51

46.31

2.1

2.0

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1450

10041

1.56

45.17

2.0

1.9

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2010

14997

1.47

43.62

1.8

13994409.44

27172550.02

pmol/l

0.80

1665

12108

(3035350) Ketones [Presence] in Urine by Test strip

3944

33351

1.41

42.40

5.3

4.3

3.48

3.54

estimate

0.01

863

7437

(3018418) pH of Serum or Plasma

2716

21558

1.42

41.84

3.4

4.4

7.40

8.76

1962

15646

(3021601) Nitrite [Presence] in Urine by Test strip

3896

32960

1.40

41.24

5.3

4.3

0.00

estimate

0.16

834

7184

(3009261) Glucose [Presence] in Urine by Test strip

3954

33565

1.40

40.84

5.4

4.4

0.01

0.35

estimate

0.96

820

6894

(3023368) Bacteria identified in Blood by Culture

2731

21797

1.41

40.33

4.4

4.6

—

(3037467) Urinalysis macro (dipstick) panel - Urine

4851

42828

1.42

38.77

5.9

5.1

1.83

1.97

0.08

(3015736) pH of Urine

3213

26537

1.38

37.97

4.5

3.8

6.32

6.27

1.88

1721

14276

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1324

9330

1.51

37.17

2.0

1.9

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

133

5.46

37.12

2.7

2.5

147.41

138.93

nmol/l

0.24

120

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2977

24382

1.38

36.55

5.5

4.4

0.81

0.34

estimate

0.27

679

5909

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

121

360

3.40

33.58

1.0

1.1

4.75

13.57

nmol/l

0.93

(3019150) Specific gravity of Urine by Refractometry

1913

14732

1.41

33.15

5.5

4.6

1.02

1.12

kg/l

0.46

1295

10111

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

304

1455

2.14

32.68

1.4

1.3

483.76

600.39

mg/l

4.52

288

1379

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

272

1260

2.20

31.76

1.4

324.08

1086.26

e6/l

2.94

232

986

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

269

1247

2.20

31.35

1.4

1.3

3.92

30.53

e6/l

2.95

213

909

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3234

27330

1.34

30.35

5.0

4.5

51.72

86.11

ng/l

1.27

2667

21895

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

147

525

2.84

29.93

1.0

270.09

321.96

ng/l

1.68

100

362

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

146

525

2.82

29.36

1.0

635.01

712.84

ng/l

1.43

352

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

146

525

2.82

29.36

1.0

34.45

42.13

ng/l

1.88

356

(3002582) Erythrocytes [#/volume] in Urine

2825

23517

1.33

28.92

4.1

3.8

72.25

96.80

e6/l

0.48

2252

18341

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4802

43247

1.34

27.75

4.3

15.43

15.10

pmol/l

15.42

4347

38763

(3030467) Casts [#/volume] in Urine by Automated count

2465

20330

1.33

26.14

4.0

3.6

0.46

0.49

e6/l

0.19

1914

15340

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

260

1286

2.06

25.66

1.3

1.2

3.87

3.88

mmol/l

0.07

245

1210

(3024561) Albumin [Mass/volume] in Serum or Plasma

3637

31685

1.30

25.66

4.1

5.3

34.82

34.60

g/l

1.44

3373

29497

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3190

27336

1.30

25.35

2.6

2.3

—

(3018095) Leukocytes [#/volume] in Urine

3004

25592

1.30

24.73

4.9

4.4

138.53

113.59

e6/l

0.66

2286

18809

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

612

3975

1.59

24.13

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

2326

19203

1.31

23.94

5.5

4.5

0.00

estimate

1.79

733

6409

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2326

19284

1.31

22.98

2.4

2.5

2.82

2.96

mg/l

2.26

1960

16530

(36304419) Bacteria [Presence] in Urine

2299

19042

1.31

22.84

3.9

3.6

19.76

133.69

estimate

0.50

116

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3221

27877

1.28

22.79

2.4

76.80

79.56

nmol/l

6.72

2830

24489

(3013826) Glucose [Moles/volume] in Serum or Plasma

4401

39622

1.29

22.75

5.3

5.4

6.68

6.89

mmol/l

9.81

4256

37851

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

109

389

2.83

22.32

1.0

271.01

288.06

mg/l

1.77

100

352

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1979

23894

0.76

22.18

1.8

2.0

1.17

1.31

mmol/l

16.50

1621

19466

(3000850) Epithelial cells [#/volume] in Urine

2039

16679

1.31

22.02

3.0

2.9

4.84

4.51

e6/l

0.86

1874

15217

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

725

5048

1.49

20.67

2.0

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1916

15786

1.29

19.04

5.0

4.1

0.33

0.41

0.10

212

(3012516) Albumin [Mass/volume] in Urine

2026

24038

0.78

18.85

3.2

3.5

38.43

51.26

mg/l

2.34

1364

15712

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1582

12758

1.31

18.37

3.6

3.3

1.30

1.36

e6/l

0.09

914

7114

(3026782) Osmolality of Urine

1738

14281

1.29

17.35

3.5

3.2

551.34

535.99

mosm/kgh2o

2.36

1546

12556

(3008152) Bicarbonate [Moles/volume] in Arterial blood

708

5081

1.44

17.13

5.9

6.8

25.56

24.45

mmol/l

13.19

674

4872

(3041096) Erythrocytes [Presence] in Urine by Automated

1982

16601

1.27

16.85

4.8

3.9

0.12

0.29

estimate

0.74

644

5568

(3009508) Creatinine [Moles/volume] in Urine

2077

24322

0.79

16.66

3.2

3.5

7.34

7.25

mmol/l

0.45

1717

20081

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

102

412

2.50

16.46

2.6

2.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1760

14651

1.27

15.52

2.5

3.2

2.45

2.46

mmol/l

5.70

1570

13077

(3015377) Calcium [Moles/volume] in Serum or Plasma

2722

23794

1.23

15.50

2.5

3.6

2.35

mmol/l

1.08

2443

21320

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5557

52462

1.27

14.93

5.8

5.4

1.93

2.05

mu/l

11.17

5097

47362

(3020682) Albumin/Creatinine [Ratio] in Urine

2122

24581

0.81

14.92

3.9

4.2

6.14

9.42

mg/mmol

6.20

1390

15503

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3020

26832

1.22

14.29

2.9

3.2

142.92

160.99

ug/l

3.25

2730

24460

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1424

11724

1.27

13.49

3.8

3.5

2.58

1.99

e6/l

1.38

748

6065

(3023410) Appearance of Cerebral spinal fluid

113

525

2.17

13.31

1.4

—

(4034850) Laboratory test

295

1863

1.61

13.08

11.6

12.3

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

4797

44843

1.21

12.62

4.3

4.7

12.54

14.48

mm/h

15.94

4441

41360

(3014051) Protein [Presence] in Urine by Test strip

1932

16566

1.23

12.58

4.0

3.3

0.17

0.07

1.06

590

(40761535) Cells panel - Urine sediment

736

5615

1.35

12.22

3.6

—

1.00

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

5.12

12.19

2.4

1.6

16.54

17.21

umol/l

0.12

(3014271) Vancomycin [Susceptibility]

441

2.22

12.10

3.8

2.8

—

(3003396) Base excess in Arterial blood by calculation

1160

9452

1.27

11.82

5.5

7.2

1.62

0.91

mmol/l

8.23

986

7728

(3019977) pH of Arterial blood

1167

9517

1.27

11.81

5.5

7.3

7.42

1.56

686

5263

(4035726) Immunohistochemistry procedure

435

6083

0.70

11.81

1.2

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

123

625

1.98

11.48

1.2

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

413

2889

1.46

11.43

1.8

2.2

1049.91

706.40

ug/l

0.24

387

2760

(40768804) Tissue Pathology biopsy report

2155

24455

0.83

11.35

2.1

2.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

296

2.45

11.33

1.1

1.4

—

(4024509) Urine culture

462

3313

1.42

11.18

2.3

2.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

119

614

1.95

10.66

1.3

1.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1158

9549

1.25

10.57

5.5

7.3

5.20

5.06

kpa

4.44

1107

9165

(3027801) Oxygen [Partial pressure] in Arterial blood

1157

9545

1.25

10.51

5.5

7.3

11.81

11.96

kpa

0.42

1102

9157

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

560

4192

1.36

10.50

2.7

0.65

0.62

1.05

560

4175

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

557

4168

1.36

10.46

4.4

4.2

47.49

46.22

0.62

547

4104

(3019198) Lymphocytes [#/volume] in Blood

3523

32304

1.18

10.45

6.1

6.2

1.76

1.85

e9/l

0.76

3050

27852

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1565

13369

1.22

10.22

1.7

1.43

1.54

mg/l

0.66

1274

10593

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

143

3.02

10.20

2.2

2.0

—

(3022621) pH of Urine by Test strip

660

5094

1.33

10.09

3.7

3.0

6.15

6.04

2.31

467

3699

(3006315) Basophils [#/volume] in Blood

3469

31835

1.17

10.01

5.9

6.1

0.04

e9/l

17.68

2926

26826

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

145

2.98

9.96

2.2

2.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

852

6817

1.28

9.96

3.1

4.43

4.42

kpa

0.02

828

6617

(3001604) Monocytes [#/volume] in Blood

3453

31691

1.17

9.91

5.9

6.1

0.58

0.63

e9/l

22.52

2919

26674

(3043409) Potassium [Moles/volume] in Arterial blood

317

2192

1.47

9.36

3.7

4.3

3.84

3.92

mmol/l

2.69

312

2170

(3030981) Hyaline casts [#/volume] in Urine by Automated count

790

6335

1.28

9.05

2.6

2.7

0.58

0.46

e6/l

0.70

755

6124

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2768

25105

1.17

8.87

3.0

3.4

1287.41

1777.35

ng/l

11.28

2415

22083

(3013115) Eosinophils [#/volume] in Blood

3535

32671

1.16

8.86

6.3

0.18

0.20

e9/l

9.82

3042

27951

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

669

8405

0.77

8.81

2.9

4.3

48.39

23.03

ug/l

0.29

540

7034

(3016502) Oxygen saturation in Arterial blood

1035

8591

1.24

8.79

5.7

7.5

95.16

95.27

0.19

992

8291

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1431

12294

1.21

8.64

2.2

3.2

0.83

0.81

mmol/l

6.35

1313

11490

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

416

5569

0.73

8.63

1.4

1.5

—

(3018405) Lactate [Moles/volume] in Arterial blood

369

2668

1.40

8.57

3.5

3.9

1.25

1.41

mmol/l

3.18

360

2622

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5876

56655

1.21

8.49

22.9

20.4

28.14

28.06

mg/l

0.06

5192

48399

(3027945) Reticulocytes/Erythrocytes in Blood

1169

9874

1.22

8.38

2.0

2.5

1.66

1.79

4.73

1016

8700

(3045414) Leukocytes [Presence] in Urine

820

6673

1.26

8.29

2.4

2.2

0.00

0.01

estimate

1.02

135

1250

(3036481) Cortisol [Moles/volume] in Serum or Plasma

701

5599

1.28

8.28

1.9

2.4

396.20

383.28

nmol/l

0.92

630

5165

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2378

21413

1.17

8.18

2.5

2.7

55.65

64.91

u/l

1.75

2199

19748

(3026493) Urate [Moles/volume] in Serum or Plasma

1568

17884

0.84

8.06

2.5

3.1

336.23

360.76

umol/l

16.43

1310

15374

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

469

1.93

7.95

1.2

1.93

2.25

mmol/l

3.74

441

(3023183) Ammonium ion [Moles/volume] in Plasma

237

1600

1.50

7.94

1.7

2.5

28.81

33.30

umol/l

1.41

201

1402

(3032080) INR in Blood by Coagulation assay

3722

34692

1.15

7.92

17.3

19.8

1.33

1.36

inr

1.81

3188

29304

(3002173) Hemoglobin [Mass/volume] in Arterial blood

945

7879

1.23

7.65

6.0

8.0

121.45

119.92

g/l

1.51

916

7702

(1761868) Lipid panel - Serum or Plasma

1496

17040

0.85

7.47

3.5

3.7

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

474

3647

1.32

7.43

2.4

2.5

19.36

22.30

au/ml

0.39

276

(3017143) Hepatitis C virus Ab [Presence] in Serum

374

4971

0.74

7.40

1.4

1.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

3807

35668

1.14

7.21

8.7

9.6

4.39

4.34

e9/l

0.43

3253

30622

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

434

3324

1.33

7.04

1.3

71.76

62.18

au/ml

0.35

236

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

479

3725

1.31

6.96

4.7

4.9

1.51

1.58

0.82

455

3535

(3021447) Carbon dioxide [Partial pressure] in Venous blood

968

8169

1.21

6.93

3.4

3.7

5.86

5.80

kpa

1.01

938

7957

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5059

48439

1.15

6.73

6.8

8.9

80.05

82.30

u/l

2.40

4764

45763

(3007930) Methemoglobin/Hemoglobin.total in Blood

441

3421

1.31

6.54

4.9

5.1

0.88

0.86

0.59

419

3241

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

318

1.99

6.19

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

479

3788

1.28

6.15

3.6

3.5

25.56

25.08

mmol/l

2.60

457

3672

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

125

780

1.61

6.04

1.6

1.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1604

14299

1.16

5.96

4.5

4.4

205.89

453.01

ng/l

2.63

1380

12505

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

763

9061

0.82

5.94

1.3

9.17

14.19

u/ml

1.40

271

3145

(3004119) Hemoglobin [Mass/volume] in Venous blood

617

5053

1.24

5.90

3.3

3.2

128.02

127.33

g/l

0.36

602

4904

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

223

1583

1.42

5.86

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

223

1583

1.42

5.86

1.4

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5257

54381

0.87

5.81

4.9

5.5

1.43

mmol/l

0.11

4744

49237

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1299

0.57

5.73

3.4

5.0

778.33

2433.48

iu/ml

0.58

197

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

329

1.92

5.65

1.2

1.1

267.96

317.49

mg/l

1.18

283

(3002032) Base excess in Venous blood by calculation

926

7943

1.19

5.53

3.4

3.7

2.37

1.74

mmol/l

7.20

831

6893

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5309

54831

0.87

5.51

5.0

5.6

4.30

4.39

mmol/l

8.11

4828

50050

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

670

5580

1.22

5.47

1.7

—

(3028707) Methadone [Presence] in Urine by Screen method

211

2.14

5.42

1.9

1.5

—

(3047181) Lactate [Moles/volume] in Blood

302

2285

1.34

5.40

5.5

5.9

1.12

1.35

mmol/l

7.33

273

2042

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

209

2885

0.72

5.33

1.9

2.1

3.27

3.42

ratio

1.13

170

2377

(3033705) Calcium.ionized [Moles/volume] in Venous blood

146

976

1.51

5.27

2.6

2.4

1.21

1.20

mmol/l

0.88

146

964

(3018572) Chloride [Moles/volume] in Blood

223

1615

1.39

5.27

5.9

6.8

105.21

105.00

mmol/l

0.28

203

1453

(3039000) Anion gap in Blood by calculation

223

1615

1.39

5.27

5.9

6.8

10.49

11.35

mmol/l

3.19

203

1452

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5042

52204

0.88

5.26

4.3

4.7

1.19

1.28

mmol/l

19.87

4496

46641

(4281824) Cell count and differential, peritoneal fluid

628

0.41

5.17

1.3

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

464

5719

0.80

5.17

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

348

1.85

5.12

1.3

1.1

42.68

46.49

mg/l

0.23

290

(3018010) Neutrophils/Leukocytes in Blood

3117

29218

1.12

5.10

5.8

6.4

60.23

58.76

9.49

2937

27712

(3035285) Chloride [Moles/volume] in Venous blood

147

993

1.49

5.06

2.6

2.4

106.26

105.62

mmol/l

0.82

147

981

(3041354) Potassium [Moles/volume] in Venous blood

147

993

1.49

5.06

2.6

2.4

4.10

4.12

mmol/l

0.16

147

981

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

215

2925

0.73

5.03

2.6

3.4

1257.97

2384.48

u/ml

0.40

179

2522

(3037522) Nuclear Ab [Titer] in Serum

634

7531

0.83

4.94

1.3

459.71

496.48

titre

0.26

136

1706

(40768793) Breast Pathology biopsy report

1193

0.58

4.91

1.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

828

7112

1.19

4.87

2.0

2.6

65.82

65.84

g/l

0.02

728

6427

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

290

1.90

4.85

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

543

1.65

4.79

1.1

—

3.71

—

(3022096) Basophils/Leukocytes in Blood

3133

29448

1.11

4.77

6.0

6.5

0.60

0.65

7.34

2908

27371

(3022948) Iron [Moles/volume] in Serum or Plasma

1454

13056

1.14

4.76

2.3

2.8

11.66

12.02

umol/l

1.11

1320

12042

(3012544) pH of Venous blood

951

8279

1.17

4.75

3.4

3.7

7.39

7.38

3.38

522

4880

(3006504) Eosinophils/Leukocytes in Blood

3131

29446

1.11

4.69

5.8

6.4

2.64

2.84

5.38

2905

27367

(3002030) Lymphocytes/Leukocytes in Blood

3167

29853

1.11

4.47

5.9

6.5

24.70

25.75

5.96

2961

28060

(3023520) Reticulocytes [#/volume] in Blood

900

7844

1.17

4.43

2.0

2.5

62.72

68.17

e9/l

5.68

667

5815

(3002256) Pathology report gross observation

771

8912

0.85

4.40

1.4

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

407

4995

0.80

4.39

1.4

1.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

321

2526

1.28

4.38

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

693

5924

1.19

4.32

3.1

4.1

1.23

mmol/l

0.85

583

5095

(3014111) Lactate [Moles/volume] in Serum or Plasma

823

7138

1.17

4.31

5.1

7.1

1.33

1.38

mmol/l

0.80

807

6981

(3019069) Monocytes/Leukocytes in Blood

3129

29523

1.11

4.26

6.1

6.5

8.83

9.22

12.63

2899

27433

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1367

12311

1.14

4.25

2.2

2.7

2.23

2.25

g/l

0.52

1232

11285

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

449

1.65

4.13

1.1

—

(3000330) Specific gravity of Urine by Test strip

462

3826

1.22

4.04

4.7

3.7

1.02

ratio

2.71

418

3473

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

104

0.00

4.00

0.0

1.3

—

112.45

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

258

3302

0.77

4.00

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1052

0.60

3.97

1.0

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3161

29913

1.10

3.96

2.7

3.0

—

estimate

—

(21494755) Public health laboratory ask at order entry panel

129

1814

0.71

3.78

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

316

1.75

3.77

1.7

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

246

1911

1.30

3.76

2.2

2.4

127.40

126.84

g/l

0.14

209

1473

(40768800) Prostate Pathology biopsy report

149

2042

0.72

3.74

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

322

2592

1.25

3.69

1.1

2.36

1.00

u/ml

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

420

0.40

3.68

1.9

2.3

19.20

30.96

iu/ml

—

(3022145) Colonoscopy Study observation

636

7357

0.85

3.67

1.3

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

253

1980

1.29

3.66

3.2

3.7

1.73

1.98

index

0.31

116

1048

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

620

5330

1.18

3.64

6.4

9.0

1.30

1.31

0.04

613

5299

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

621

0.51

3.62

1.6

1.5

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

240

1.84

3.59

1.4

1.2

0.54

0.53

ratio

0.09

141

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

137

2.12

3.54

1.1

1.2

0.50

74.96

mg/l

0.81

100

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

163

2173

0.74

3.45

1.2

1.3

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3695

35371

1.09

3.42

4.7

6.9

11.70

12.48

umol/l

3.55

3508

33722

(3028026) IgM [Mass/volume] in Serum or Plasma

302

3713

0.81

3.37

1.8

1.9

1.51

1.36

g/l

0.27

269

3356

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5480

56075

0.90

3.36

5.8

6.5

2.44

2.50

mmol/l

6.64

4960

51015

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

906

0.62

3.32

1.1

1.4

159.00

159.39

au/ml

0.01

266

(3011288) Drugs identified in Urine by Screen method Nominal

269

1.75

3.31

1.7

1.9

—

(3006270) Folate [Moles/volume] in Blood

582

1.50

3.28

1.2

307.01

327.26

nmol/l

0.43

455

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

928

8286

1.14

3.28

8.2

8.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1351

12340

1.12

3.27

4.7

5.0

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

926

0.62

3.26

1.1

1.2

—

98.15

—

(3007853) Bacteria identified in Skin by Aerobe culture

894

7970

1.14

3.23

1.9

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

596

5162

1.17

3.22

6.6

9.3

0.69

0.63

3.46

590

5129

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

148

1978

0.74

3.21

1.6

1.9

3.24

3.36

mmol/l

0.71

108

1462

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1341

0.69

3.20

1.3

1.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

310

1.68

3.18

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1264

11522

1.12

3.17

1.3

1.75

1.76

u/ml

0.02

326

2850

(3013166) Neutrophils/Leukocytes in Synovial fluid

214

1.83

3.16

1.4

1.3

62.46

57.88

0.28

180

(3000764) Benzodiazepines [Presence] in Urine

411

1.59

3.16

1.6

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1144

0.67

3.11

1.1

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

4.50

3.11

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

145

2.00

3.09

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

115

1584

0.72

3.05

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

427

0.47

3.05

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1031

0.66

3.05

1.1

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

371

3100

1.21

3.04

2.8

3.3

4.40

4.34

pmol/l

0.54

319

2720

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

130

952

1.37

3.04

1.9

2.1

33.19

25.19

mg/l

0.72

328

(4198724) Urine methamphetamine measurement

2.50

3.03

2.0

1.3

—

(3028300) Cannabinoids [Presence] in Urine

416

1.57

3.02

1.6

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

618

1.46

3.02

2.4

2.0

1.29

1.26

u/field

0.02

331

(3042631) Mycobacterium sp identified in Specimen

1147

0.68

3.00

2.4

2.8

—

(1761482) Bacteria [#/volume] in Urine by Culture

246

1972

1.26

2.99

6.2

4.4

—

(3045424) Erythrocytes [Presence] in Urine

400

3373

1.20

2.98

2.2

0.00

0.28

estimate

0.53

109

942

(3044640) Blood type and Crossmatch panel - Blood

2310

21757

1.09

2.97

2.4

2.7

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

340

1.62

2.96

1.2

1.6

5.71

6.42

u/l

0.30

288

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

136

1809

0.75

2.89

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

413

3507

1.19

2.86

1.8

1.9

2.37

ug/l

0.00

345

3085

(3003181) Sodium [Moles/volume] in Urine

194

1522

1.28

2.84

1.3

1.4

71.94

61.04

mmol/l

3.23

151

1232

(3027008) Opiates [Presence] in Urine

415

1.55

2.83

1.7

1.4

—

(3008295) Osmolality of Serum or Plasma

111

803

1.39

2.82

1.4

1.3

282.96

276.13

mosm/kgh2o

1.89

594

(3033658) Prothrombin time (PT) actual/Normal

1795

16754

1.10

2.81

3.9

4.4

83.57

83.83

0.18

1757

16410

(3024891) Influenza virus A+B Ag [Presence] in Specimen

164

1261

1.31

2.80

1.3

1.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1252

11483

1.11

2.80

2.3

2.8

21.28

21.51

0.24

1132

10592

(1617658) Protocol used for examination of sentinel lymph nodes

371

0.46

2.78

1.0

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

102

1407

0.72

2.77

1.5

34.58

31.38

g/l

2.07

1258

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

839

0.64

2.75

1.1

1.2

282.34

292.80

u/ml

0.09

505

(3027944) Amphetamines [Presence] in Urine

403

1.54

2.73

1.6

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

167

1.86

2.70

1.0

1.1

—

(3016879) Cocaine [Presence] in Urine

389

1.55

2.68

1.7

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

126

940

1.35

2.66

3.3

14.4

7.03

7.41

mmol/l

0.83

105

778

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

183

1.81

2.64

1.2

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

4.67

2.59

1.0

1.1

—

(40768441) Liver Pathology biopsy report

440

0.52

2.59

1.1

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

879

9703

0.89

2.57

1.3

35.83

39.47

iu/ml

0.24

262

2873

(3005719) IgG [Mass/volume] in Serum or Plasma

404

4698

0.85

2.55

2.8

10.11

10.63

g/l

1.62

360

4311

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

738

8224

0.89

2.54

5.1

5.4

34.72

33.34

2.68

467

5227

(3012441) Differential panel - Pleural fluid

1058

0.70

2.51

1.6

1.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

6008

59096

1.11

2.50

27.9

25.0

139.73

139.59

mmol/l

4.01

5926

57884

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

276

2291

1.21

2.48

2.0

2.4

0.00

g/l

-0.00

252

2117

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

198

1587

1.25

2.47

1.1

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

285

0.42

2.47

1.9

2.0

528.00

4054.29

e6/l

—

190

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

157

1998

0.78

2.45

2.1

2.7

1.52

1.77

mg/l

3.57

138

1770

(3007566) Smooth muscle Ab [Titer] in Serum

116

1536

0.75

2.45

1.1

1.2

228.00

130.75

titre

—

134

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

642

5712

1.14

2.44

2.9

3.9

86.40

98.66

ng/l

1.78

525

4818

(40768795) Lymph node Pathology biopsy report

692

0.63

2.41

1.0

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

358

3056

1.18

2.38

1.9

2.4

0.41

0.99

g/l

4.59

299

2582

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

245

2958

0.82

2.38

2.5

2.8

0.40

0.34

iu/ml

1.45

149

1637

(3023103) Potassium [Moles/volume] in Serum or Plasma

6012

59168

1.10

2.37

28.0

25.2

3.98

4.01

mmol/l

11.97

5923

57879

(3029634) Reagin Ab [Titer] in Serum by VDRL

590

0.61

2.36

1.4

1.9

—

3.45

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

4.12

2.36

1.3

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

748

6738

1.12

2.33

3.1

3.2

202.57

242.42

ng/l

2.24

688

6230

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

824

7464

1.12

2.33

4.6

3.9

—

(3044007) Cell count panel - Peritoneal fluid

249

0.40

2.32

2.3

1.7

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

487

0.57

2.32

1.1

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.18

2.30

1.1

1.2

—

(3003694) ABO and Rh group [Type] in Blood

1672

15684

1.09

2.29

1.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

253

1.62

2.29

1.1

226.71

655.04

ng/l

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

372

1.51

2.29

1.6

1.9

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

302

2552

1.19

2.28

2.0

2.4

0.03

0.04

g/l

0.34

268

2267

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.22

2.27

1.6

1.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

187

0.37

2.26

1.7

1.4

29.51

26.28

g/l

—

147

(3023430) Cat dander IgE Ab [Units/volume] in Serum

314

0.48

2.25

1.0

1.1

0.38

2.09

u/ml

—

139

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

704

0.65

2.25

1.1

1.2

123.71

188.74

miu/ml

—

202

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

894

0.69

2.24

1.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

240

1988

1.21

2.24

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.28

2.24

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

197

1600

1.24

2.22

1.1

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

111

1456

0.76

2.22

1.3

1.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.10

2.22

1.1

1.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

376

1.49

2.19

2.5

2.2

14.12

27.57

umol/l

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

4521

44034

1.07

2.19

30.5

26.9

331.05

331.31

g/l

1.23

4483

43726

(3023199) Leukocytes [#/volume] in Pleural fluid

1213

0.74

2.18

1.5

2730.03

2866.39

e6/l

0.04

855

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

165

1.76

2.18

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

625

0.64

2.16

1.1

1.2

0.59

0.63

ratio

0.41

138

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

436

4968

0.87

2.14

1.3

1.4

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

166

1.75

2.14

1.6

1.5

96.31

420.46

nmol/24h

1.08

166

(42529406) Shigella sp [Presence] in Stool by Culture

197

1608

1.23

2.14

1.1

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1257

11682

1.09

2.14

1.9

2.0

29.80

29.99

0.47

1221

11356

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3662

35430

1.07

2.13

3.3

3.4

47.67

57.07

u/l

5.10

3356

32421

(40758558) Short blood count panel - Blood

2008

19027

1.08

2.12

6.5

6.6

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

461

0.58

2.11

1.3

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

279

0.46

2.11

1.1

1.0

0.05

0.20

u/ml

—

110

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

345

0.52

2.10

1.2

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

345

0.52

2.10

1.2

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

345

0.52

2.10

1.2

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

345

0.52

2.10

1.2

1.9

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.20

2.09

2.3

1.4

452.70

337.61

nmol/l

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

135

1710

0.79

2.08

2.5

3.4

996.19

806.51

u/ml

0.09

122

1557

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

443

3890

1.15

2.08

2.5

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.56

2.07

1.2

1.1

—

(3042517) Benzodiazepines panel - Urine

5.00

2.07

1.0

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.70

2.06

1.1

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

523

1.40

2.06

1.5

1.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

199

1634

1.22

2.05

1.6

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.18

2.04

1.1

—

(3017509) Phencyclidine [Presence] in Urine

4.00

2.04

1.2

—

(3016228) CD19 cells/cells in Blood

260

0.46

2.01

2.2

1.9

4.00

6.84

1.26

246

(3008536) Aspergillus sp Ab [Presence] in Serum

145

0.34

2.00

1.2

1.8

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

288

2456

1.18

1.99

2.0

2.4

0.00

g/l

0.50

252

2125

(3010726) Horse dander IgE Ab [Units/volume] in Serum

377

0.56

1.99

1.0

1.1

0.43

0.84

u/ml

0.76

196

(3045142) Bone marrow Pathology biopsy report

916

0.72

1.96

1.0

1.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

676

7449

0.90

1.95

4.3

6.9

10.23

11.22

mmol/l

3.01

618

7090

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

182

2211

0.82

1.95

1.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

249

1.57

1.94

1.1

1.02

1.22

u/l

2.01

112

(46235355) HIV 1 and 2 tests - Meaningful Use set

541

6035

0.89

1.94

1.4

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

692

1.33

1.94

1.3

1.4

183355.62

172742.96

e6/l

0.04

460

(3014133) Dog dander IgE Ab [Units/volume] in Serum

335

0.54

1.93

1.1

1.44

2.53

u/ml

—

168

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

142

1769

0.80

1.93

1.9

2.1

92.34

88.81

1.17

137

1709

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.45

1.92

1.2

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

713

0.69

1.91

1.1

1.3

1.54

1.52

g/l

0.22

713

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2379

22752

1.07

1.90

4.9

5.1

22.27

22.23

0.05

1266

12487

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

323

2796

1.16

1.88

2.0

1.9

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

4592

44857

1.07

1.87

27.7

25.4

13.77

13.93

14.20

4534

44220

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

151

1.72

1.86

1.1

—

(40768806) Pleura Pathology biopsy report

1042

0.75

1.84

1.7

1.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

1087

0.75

1.83

1.5

80032.48

63116.75

e6/l

0.31

614

(3043410) Blood group antigens tested for on Red Blood Cells

198

1.62

1.82

1.5

1.9

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2933

28270

1.06

1.82

5.6

6.3

4.48

3.89

ug/l

0.25

2625

25303

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

168

1.67

1.80

1.7

1.5

0.40

0.39

ug/l

0.03

103

(3004809) Band form neutrophils/Leukocytes in Blood

104

1331

0.78

1.79

2.6

3.7

2.44

1.66

0.55

1170

(3021589) Normoblasts [#/volume] in Blood

2802

26981

1.06

1.79

13.6

13.1

0.00

e9/l

0.03

2221

21868

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

138

1.74

1.79

1.0

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

176

1.65

1.78

1.3

1.5

13.37

16.78

pmol/l

2.60

141

(3019225) pH of Specimen

768

7040

1.10

1.78

3.9

4.6

7.36

0.23

546

4998

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

304

1.48

1.77

1.6

1.9

305.59

338.93

mu/l

0.28

234

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

246

0.49

1.76

1.8

1576.00

20558.70

e6/l

—

129

(3000991) Gas panel - Venous blood

746

6834

1.10

1.75

6.1

8.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

102

792

1.29

1.75

2.1

1.8

285.31

299.18

mu/l

0.23

737

(1616796) Gas panel - Central venous blood

209

1757

1.20

1.74

3.4

4.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

376

3312

1.14

1.74

1.9

2.4

2.94

2.93

g/l

0.03

326

2959

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

162

1330

1.22

1.73

1.5

1.8

3.92

8.91

iu/l

0.49

464

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

225

1.56

1.72

3.0

2.9

28.08

28.86

umol/l

0.12

169

(3033086) Enterovirus Ab [Titer] in Serum

3.85

1.71

1.0

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

500

4490

1.12

1.71

3.2

3.7

2.31

1.91

mmol/l

1.79

374

3300

(3006571) Granulocytes/Leukocytes in Synovial fluid

858

0.73

1.71

1.9

1.5

59.83

62.25

0.20

550

(40761536) Microorganisms panel - Urine sediment

557

5035

1.12

1.69

5.8

4.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

401

3557

1.13

1.68

1.8

2.4

7.25

7.47

g/l

1.94

351

3200

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

5352

54389

0.94

1.68

21.7

20.5

77.10

72.48

ml/min/173m2

65.77

5068

51003

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

164

1.65

1.67

1.0

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

400

3551

1.13

1.66

1.8

2.4

3.57

3.76

g/l

2.20

351

3197

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

204

1.57

1.64

1.2

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

252

0.51

1.63

1.4

2.1

—

(40768446) Kidney Pathology biopsy report

212

0.47

1.63

1.3

1.5

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

262

3027

0.86

1.63

1.7

1.6

17.72

18.45

iu/ml

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

400

3557

1.13

1.62

1.8

2.4

4.10

4.17

g/l

1.15

351

3206

(3033099) Centromere Ab [Titer] in Serum

130

0.38

1.62

1.4

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

251

0.52

1.61

1.2

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

251

0.52

1.61

1.2

2.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

168

2011

0.83

1.60

1.7

1.4

4.58

16.11

iu/ml

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

230

1.52

1.59

2.3

2.1

52.14

54.45

umol/l

0.13

194

(3016650) Hepatitis A virus Ab [Presence] in Serum

844

0.74

1.56

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

505

4568

1.11

1.54

3.0

3.7

24.95

24.10

mmol/l

7.93

497

4507

(3017569) Oxygen content in Arterial blood

509

1.34

1.54

2.2

2.1

15.98

15.94

0.03

509

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

762

7036

1.09

1.54

2.4

2.5

6.30

7.16

ug/l

0.91

594

6122

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.97

1.53

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

484

1.35

1.53

1.2

106.72

104.54

pmol/l

0.12

484

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

1.52

0.0

3.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

347

3073

1.14

1.52

1.9

2.4

9.92

10.24

g/l

0.89

296

2681

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

142

0.42

1.51

1.2

1.1

—

(3009343) pH of Capillary blood

563

5131

1.11

1.50

3.4

3.9

7.42

4.55

464

4265

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1007

0.77

1.49

1.3

1.5

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

128

0.39

1.48

1.6

4.4

25.20

56.16

u/l

—

122

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

802

0.75

1.48

1.0

1.1

1.52

1.56

g/l

0.38

732

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

547

0.69

1.47

1.1

1.16

1.42

u/ml

0.13

300

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

105

840

1.25

1.46

1.1

1.3

238.95

281.20

pmol/l

1.15

695

(21494814) CD8 cells/Lymphocytes in Specimen

255

0.55

1.46

2.1

1.9

32.29

33.09

0.06

255

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

577

5274

1.10

1.45

3.4

3.9

5.23

5.14

kpa

1.87

539

5007

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

263

3008

0.87

1.45

2.9

2.7

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

170

0.47

1.45

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

219

1.51

1.45

3.6

6.7

70.57

71.84

0.09

174

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

604

0.71

1.45

1.1

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

604

0.71

1.45

1.1

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

604

0.71

1.45

1.1

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

159

1890

0.84

1.43

1.3

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

152

0.46

1.43

2.1

1.6

11.26

9.94

ug/l

—

152

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

125

1518

0.82

1.42

1.2

1.3

3.03

5.73

u/ml

1.55

232

(3024263) Appearance of Synovial fluid

362

1.38

1.41

1.8

1.5

—

(3002179) Metamyelocytes/Leukocytes in Blood

544

5949

0.91

1.41

3.4

4.1

1.21

0.71

1.27

134

1956

(3020876) Protein [Mass/time] in 24 hour Urine

1065

0.79

1.41

1.8

2.3

0.50

1.18

g/24h

5.57

618

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

1.85

1.39

1.3

1.1

22.80

49.54

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

288

1.43

1.38

1.4

1.6

1.46

331.33

u/l

0.91

101

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

137

1643

0.83

1.37

2.3

2.4

188.85

211.03

2.65

130

1568

(3010838) Calcium [Moles/time] in 24 hour Urine

128

1056

1.22

1.37

1.6

1.8

4.42

4.50

mmol/24h

0.11

113

900

(40768443) Skin Pathology biopsy report

276

3129

0.88

1.36

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

207

1.50

1.34

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

0.00

1.34

0.0

1.0

—

1.55

—

(3024316) Viscosity of Plasma

0.00

1.34

0.0

1.7

—

1.67

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

167

1.56

1.34

1.5

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

358

0.64

1.33

3.3

2.5

40.00

37.29

0.37

205

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

133

1593

0.83

1.32

1.2

72.90

36.88

u/ml

—

(3011985) Renin [Units/volume] in Plasma

111

906

1.23

1.32

1.2

1.4

32.93

64.75

mu/l

2.08

802

(3004616) Nuclear Ab [Presence] in Serum

752

0.76

1.31

1.3

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

507

4632

1.10

1.31

7.4

9.5

16.14

15.85

1.65

485

4482

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

160

1.56

1.31

1.0

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

1.31

0.0

4.2

—

0.00

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

220

0.54

1.31

2.2

1.8

1.92

1.70

ratio

0.20

206

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

126

1514

0.83

1.30

1.2

1.3

3.07

4.92

u/ml

0.40

152

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

115

1393

0.82

1.29

1.1

1.2

397.50

279.86

titre

—

109

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1736

16628

1.06

1.28

2.3

2.7

—

(3020491) Glucose [Moles/volume] in Blood

448

1.32

1.26

2.1

7.61

7.09

mmol/l

0.45

303

(3047189) Immunofixation for 24 hour Urine

411

0.68

1.24

1.3

1.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

893

9502

0.93

1.23

2.7

4.3

230.53

248.09

u/l

4.31

836

8971

(3048689) Calprotectin [Mass/mass] in Stool

682

6337

1.08

1.23

2.1

189.52

163.53

ug/g

0.90

555

4974

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

160

1870

0.85

1.22

2.0

2.3

3.58

3.63

g/l

0.17

149

1788

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

147

1.57

1.22

1.1

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

336

3018

1.12

1.22

2.0

—

(3013512) EKG study

2401

24798

0.95

1.20

4.5

4.2

0.86

0.76

—

(3004451) EKG impression Narrative

496

1.29

1.20

1.3

—

(3048879) Bone marrow aspiration report

226

0.57

1.20

1.1

1.6

—

2.00

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

167

0.54

1.18

5.9

7.4

5.97

5.41

kpa

—

167

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

358

0.67

1.17

1.7

1.3

0.91

1.74

u/ml

0.44

210

(3037692) Legionella sp identified in Specimen by Organism specific culture

261

0.61

1.16

1.1

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

749

1.23

1.16

2.5

3.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

1.16

0.0

1.1

—

0.22

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

2.50

1.15

1.6

1.1

1.22

1.26

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

320

0.66

1.14

1.2

1.3

12.41

392.49

ug/l

—

154

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

149

1738

0.85

1.13

1.3

1.5

0.41

8.94

iu/ml

1.20

380

(3023419) Bacteria identified in Sputum by Culture

1055

0.81

1.13

2.2

2.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1596

16627

0.95

1.12

3.4

3.6

0.75

0.83

ug/l

3.14

1159

12076

(36660697) Celiac disease serology panel - Serum

446

4090

1.10

1.11

1.2

—

(40757373) Influenza virus identified in Isolate

143

1.54

1.11

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

931

0.80

1.11

1.4

6.11

6.38

mmol/l

0.38

863

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

149

1277

1.17

1.10

1.8

1.6

—

30.85

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

741

0.78

1.10

1.2

2.17

4.54

u/ml

1.36

253

(3020564) Creatinine [Moles/volume] in Serum or Plasma

6040

59828

1.06

1.09

29.5

27.5

78.34

85.27

umol/l

51.65

5978

58930

(3008401) Mugwort IgE Ab [Units/volume] in Serum

434

0.71

1.09

1.0

1.1

0.55

0.97

u/ml

0.46

184

(3044889) 12 lead EKG panel

4339

42629

1.05

1.09

4.7

4.8

0.50

1105.32

—

110

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

181

0.55

1.08

1.0

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

338

1.33

1.07

1.9

1.8

1.00

2.36

u/field

2.34

225

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

1.69

1.07

1.2

68.86

76.93

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

581

0.76

1.07

1.6

1.3

6.82

6.99

g/l

0.11

422

(3024139) IgG subclass 3 [Mass/volume] in Serum

581

0.76

1.07

1.6

1.3

0.38

0.45

g/l

0.81

423

(3028192) IgG subclass 2 [Mass/volume] in Serum

581

0.76

1.07

1.6

1.3

2.29

2.97

g/l

2.80

425

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

671

0.77

1.07

1.1

1.7

—

(3045788) Cell count panel - Pleural fluid

981

0.81

1.06

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

109

1296

0.84

1.06

1.5

1.7

2.94

4.76

mg/l

1.83

992

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

112

1328

0.84

1.05

1.2

2.35

4.33

u/ml

0.46

(3017354) Segmented neutrophils/Leukocytes in Blood

836

0.80

1.05

2.5

3.6

57.94

58.51

0.06

702

(3027456) Digoxin [Moles/volume] in Serum or Plasma

179

2044

0.87

1.04

3.3

0.74

0.82

nmol/l

2.36

143

1643

(3000285) Sodium [Moles/volume] in Blood

170

1.47

1.04

1.2

1.3

138.00

138.69

mmol/l

0.37

137

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

254

1.38

1.04

1.5

1.4

172.00

108.31

umol/l

0.36

144

(3017704) Immunofixation for Urine

464

0.73

1.04

1.3

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

768

0.79

1.04

3.0

4.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

383

0.70

1.03

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

138

1.52

1.02

1.2

1.3

105.21

110.55

0.26

119

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

497

0.74

1.02

1.4

1.5

—

(3017181) Myelocytes/Leukocytes in Blood

584

6261

0.93

1.02

3.6

4.2

0.82

0.96

0.67

143

2070

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.92

1.02

1.1

0.02

0.03

u/ml

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

229

2568

0.89

1.01

1.3

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

275

0.65

1.01

4.1

4.6

—

58.83

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

226

0.62

1.00

1.2

1.4

40.71

23.15

1.01

187

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

239

1.38

1.00

1.8

2.4

5.15

4.89

kpa

0.34

239

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

440

1.27

0.99

1.4

1.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

240

1.38

0.98

1.8

2.4

9.60

10.06

kpa

0.66

240

(4062490) Immunoglobulin typing, IgG

572

0.77

0.98

1.6

1.3

—

(3000012) Reticulocyte production index

152

1322

1.15

0.96

1.7

2.1

0.78

0.89

1.99

105

927

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

267

1.35

0.95

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

117

1366

0.85

0.94

1.3

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

235

2107

1.12

0.94

1.4

1.5

275.59

259.81

ug/g

0.60

155

1311

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

724

0.80

0.94

1.2

2.43

5.00

u/ml

2.41

333

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.65

0.94

1.0

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

877

0.82

0.93

1.8

2.0

—

(3021440) Promyelocytes/Leukocytes in Blood

559

5978

0.93

3.7

4.3

0.12

0.06

121

1796

(3036048) Francisella tularensis Ab [Titer] in Serum

120

0.50

0.93

1.0

1.2

—

568.00

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

420

0.74

0.93

2.8

1.9

—

(3051611) Lipemic interference index of Serum or Plasma

743

1.20

0.92

3.1

3.6

14.12

12.60

index

0.40

398

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

526

4905

1.08

0.92

1.6

1.7

1.50

1.60

2.85

456

4068

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

677

0.80

0.91

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5387

54452

0.96

0.91

7.2

7.5

40.02

40.53

mmol/mol

4.23

4947

49965

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

687

0.80

0.90

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

440

0.75

0.89

1.4

1.8

—

(3044927) Protein electrophoresis panel - Urine

101

858

1.18

0.88

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

988

0.84

0.86

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

540

1.22

0.85

1.3

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

481

0.77

0.85

1.4

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

177

1988

0.89

0.85

1.3

1.5

0.23

0.32

mg/l

1.73

886

(3028717) Thiamine [Mass/volume] in Blood

1.63

0.84

1.2

58.00

65.04

ug/l

0.88

(3025159) Blasts/Leukocytes in Blood

561

5972

0.93

0.84

3.8

4.4

0.83

0.16

0.45

118

1699

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

137

1.46

0.83

1.3

1.4

71.27

80.01

0.43

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

196

1.38

0.83

1.1

1.2

—

(4268621) Lupus anticoagulant assay

513

0.78

0.83

2.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

101

1178

0.86

0.83

1.2

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

154

1.43

0.83

1.5

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

115

0.52

0.82

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.88

0.81

1.2

1.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

283

0.71

0.80

1.0

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

664

1.19

0.80

1.6

1.7

38.00

25.42

u/ml

1.25

130

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

564

0.80

0.79

1.1

1.2

—

82.06

—

(3017732) Neutrophils [#/volume] in Blood

812

7731

1.06

0.78

3.7

3.4

4.90

4.87

e9/l

0.03

651

6434

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.78

0.0

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

163

0.61

0.78

1.1

1.3

—

(3007461) Platelets [#/volume] in Blood

6052

60069

1.05

0.78

34.3

30.8

237.13

239.32

e9/l

1.90

5941

58575

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

148

1.42

0.77

1.3

0.35

0.30

g/l

0.76

115

(3024731) MCV [Entitic mean volume] in Red Blood Cells

6052

60072

1.05

0.77

34.2

30.7

91.92

91.89

0.24

5991

59197

(3035941) MCH [Entitic mass]

6052

60072

1.05

0.77

34.2

30.6

30.45

30.49

1.04

5991

59198

(3002079) Sodium [Moles/time] in 24 hour Urine

234

1.33

0.77

1.1

1.3

188.48

166.48

mmol/24h

0.54

234

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

100

0.50

0.77

2.4

3.0

9.68

7.46

mg/l

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

126

0.56

0.77

1.0

1.1

—

(3026361) Erythrocytes [#/volume] in Blood

6052

60074

1.05

0.77

34.3

30.7

4.33

4.39

e12/l

17.84

5910

58333

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

142

1604

0.88

0.77

1.6

1.9

10.83

12.83

mg/l

2.16

132

1475

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

6052

60075

1.05

0.76

34.7

31.3

39.02

39.64

13.82

5992

59175

(3051387) C reactive protein [Mass/volume] in Capillary blood

165

1472

1.12

0.76

4.5

3.7

29.02

30.12

mg/l

0.14

116

1047

(3024980) IgG subclass 4 [Mass/volume] in Serum

953

0.85

0.76

2.1

1.5

0.54

0.90

g/l

5.13

733

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.77

0.76

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

245

0.69

0.76

1.2

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

985

0.85

0.76

1.3

1.5

—

(3012565) Volume of 24 hour Urine

314

0.73

0.76

1.2

2.3

2400.00

1817.05

1.53

260

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

323

1.27

0.75

1.1

—

(3016038) Potassium [Moles/volume] in Urine

540

1.21

0.75

1.1

34.60

35.19

mmol/l

0.09

459

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

761

1.17

0.75

1.4

1.3

0.22

0.19

nmol/l

1.73

624

(3000963) Hemoglobin [Mass/volume] in Blood

6052

60081

1.05

0.75

34.6

31.0

130.51

132.75

g/l

26.29

5993

59237

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

255

0.71

0.74

1.8

2.5

0.59

0.62

mmol/l

0.66

255

(3034891) Synovial lining cells/cells in Synovial fluid

335

0.75

0.74

1.9

1.4

1.60

3.64

—

(3000475) Leukocytes [#/volume] in Synovial fluid

203

1838

1.11

0.73

1.8

1.6

13437.58

15892.98

e6/l

0.41

154

1270

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

689

0.83

0.73

1.6

1.4

12.88

13.08

u/l

0.09

658

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

134

0.60

0.73

6.5

6.9

11.35

10.24

—

134

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

656

0.82

0.73

1.3

1.2

—

(3010813) Leukocytes [#/volume] in Blood

6051

60083

1.05

0.72

34.3

30.8

6.85

6.94

e9/l

1.74

5914

58331

(3025549) Creatine [Moles/time] in 24 hour Urine

1.61

0.72

1.1

1.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

434

1.22

0.71

1.3

0.49

1.10

promille

4.23

346

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

554

1.19

0.70

1.3

1.4

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.71

0.70

1.3

1.0

0.26

1.40

u/ml

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

443

0.79

0.69

1.0

1.1

0.78

2.56

u/ml

2.61

208

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

749

1.16

0.69

1.4

1.3

—

nmol/l

—

(21494434) Karyotype in Bone marrow

727

0.84

0.68

1.1

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

173

1914

0.90

0.68

1.2

1.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

984

0.86

0.68

1.6

1.7

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

103

901

1.15

0.67

1.4

1.3

0.72

0.20

nmol/l

4.28

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

831

0.85

0.66

3.4

3.5

3.11

21.06

nmol/l

1.24

808

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

395

0.78

0.65

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

395

0.78

0.65

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

145

1.38

0.65

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.57

0.65

1.8

1.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

219

2007

1.09

0.64

1.4

1.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.72

0.64

1.0

1.2

—

(3035880) pH of Pleural fluid

524

0.82

0.62

1.4

1.3

7.37

7.41

0.78

356

(3034426) Prothrombin time (PT)

153

0.65

0.62

1.5

1.2

26.80

28.48

—

153

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

708

0.85

0.62

1.1

1.7

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

121

1.41

0.62

1.4

1.2

0.53

0.69

umol/24h

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.63

0.62

1.5

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

103

0.58

0.62

1.0

1.3

—

4790.00

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

122

1088

1.12

0.61

5.5

6.2

12.54

12.36

mg/l

0.14

107

1006

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

137

0.66

0.60

1.0

1.5

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.60

0.0

1.6

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

198

0.71

0.60

1.0

1.6

1.84

1.93

umol/l

0.16

178

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

378

0.79

0.59

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

242

2238

1.08

0.59

1.0

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

389

0.80

0.59

1.2

1.1

73.45

87.27

u/l

0.74

340

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

1.54

0.59

1.5

1.1

—

22.07

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

322

0.78

0.59

1.0

4.0

58.50

66.34

mg/l

0.34

220

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.58

0.0

1.2

—

(40762887) Creatinine [Moles/volume] in Blood

1.51

0.58

1.6

1.8

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

150

0.67

0.58

1.8

1.5

4.20

7.52

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

1.46

0.57

1.1

1.3

92.83

74.48

—

(3024928) Oxygen saturation in Venous blood

213

1963

1.09

0.57

2.1

2.7

61.85

59.62

0.79

201

1894

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

387

0.80

0.57

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

301

1.23

0.56

1.2

1.3

34.96

33.00

u/l

0.14

247

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.45

0.56

1.0

1.2

32.00

11.18

u/l

—

(3001729) Color of Synovial fluid

1.54

0.55

1.4

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

258

2767

0.93

0.54

1.2

85.27

123.71

u/ml

1.19

932

(3044242) Glucose [Moles/volume] in Arterial blood

496

1.17

0.54

1.8

1.9

8.99

8.12

mmol/l

0.57

496

(3034092) Cytoplasmic Ig cells/cells in Blood

1.45

0.53

8.2

12.7

0.36

0.25

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

415

0.82

0.53

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

371

0.81

0.52

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

791

0.87

0.52

1.0

1.1

—

(3000494) Fungus identified in Specimen by Culture

784

7552

1.04

0.52

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

215

1993

1.08

0.52

1.4

1.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

223

1.26

0.52

1.1

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

126

1.35

0.51

2.4

1.6

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

136

0.66

0.51

2.1

2.9

104.11

1137.89

u/l

—

128

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

658

1.14

0.51

1.1

53.82

20.31

au/ml

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

135

1.33

0.51

1.3

1.2

75.10

81.45

—

(3026480) Teichoate Ab [Titer] in Serum

1.39

0.50

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

687

1.14

0.50

1.5

1.4

31.37

32.41

iu/l

0.09

576

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

660

0.86

0.50

1.4

1.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5500

55366

0.97

0.49

5.7

5.9

6.05

6.12

mmol/l

4.31

4932

49700

(40759836) Histone Ab [Presence] in Serum by Immunoblot

400

0.82

0.49

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

465

0.84

0.49

1.1

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

828

0.88

0.49

3.7

3.6

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

257

0.78

0.49

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

551

0.85

0.49

1.3

1.2

8.08

7.76

mmol/l

0.38

459

(3025577) Chromium [Mass/volume] in Blood

497

0.84

0.48

2.1

2.2

2.20

2.07

ug/l

0.10

409

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

294

2767

1.07

0.48

3.7

4.1

25.25

24.84

mmol/l

1.89

260

2499

(3005322) IgE [Units/volume] in Serum or Plasma

289

3069

0.94

0.48

1.3

390.16

261.89

u/ml

0.46

265

2818

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.47

0.47

3.8

2.6

0.60

0.40

u/field

—

(3000093) Morphology [Interpretation] in Blood Narrative

759

1.12

0.46

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

1.43

0.45

1.0

1.1

0.27

0.39

u/ml

—

(3008898) HLA-B27 [Presence]

105

1155

0.91

0.43

1.0

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

510

5311

0.96

0.43

2.1

2.2

13.16

12.51

nmol/l

1.05

446

4647

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

240

2549

0.94

0.42

1.5

1.8

37.19

38.64

u/l

0.59

203

2183

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

879

1.10

0.42

1.4

1.3

0.70

2.68

nmol/l

0.49

843

(3002619) Bacteria identified in Specimen by Culture

167

1.26

0.41

1.6

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.38

0.41

1.1

1.3

1.59

1.76

umol/24h

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

0.41

0.0

1.0

—

1.20

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

286

1.19

0.41

1.4

1.2

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

0.00

0.40

0.0

1.4

—

2.35

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

0.00

0.40

0.0

1.4

—

3.63

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

0.00

0.40

0.0

1.4

—

4.46

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

0.00

0.40

0.0

1.4

—

2.73

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

0.00

0.40

0.0

1.4

—

0.58

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

0.00

0.40

0.0

1.4

—

1.74

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

0.00

0.40

0.0

1.4

—

3.05

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

0.00

0.40

0.0

1.4

—

0.29

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

0.00

0.40

0.0

1.4

—

1.77

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

0.00

0.40

0.0

1.4

—

2.77

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.40

0.0

1.1

—

11.35

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.40

0.0

6.1

—

360.44

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

411

0.85

0.39

1.7

1.5

5.43

7.25

u/l

0.64

318

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.39

0.0

1.0

—

(3020650) Glucose [Presence] in Urine

187

1.23

0.38

1.4

1.8

0.13

0.06

estimate

0.20

187

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.39

0.38

1.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

129

1194

1.08

0.37

1.4

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1008

0.91

0.37

1.2

1.1

—

(3019174) dRVVT (LA screen)

1.35

0.37

1.0

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

132

1422

0.93

0.36

1.1

1.3

23.81

38.53

u/l

1.46

115

1226

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

426

4094

1.04

0.36

1.5

1.7

1.58

1.56

g/l

0.14

360

3522

(3001019) Free T4 and TSH panel - Serum or Plasma

103

1120

0.92

0.36

1.6

1.7

—

(4195642) Thrombophilia screening test

639

0.89

0.35

1.1

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

745

7664

0.97

0.35

2.3

2.8

7.98

9.75

umol/l

1.79

652

6761

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

159

1698

0.93

0.35

1.4

1.5

0.23

0.24

g/l

0.23

151

1612

(4212803) Bone marrow aspirate examination

0.62

0.35

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

117

1.28

0.35

1.2

1.3

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.40

0.35

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

301

1.16

0.34

1.5

1.4

152.67

185.40

pmol/l

0.48

301

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1.36

0.34

1.2

1.1

—

13.44

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

383

0.86

0.34

1.0

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

215

2269

0.95

0.33

1.4

1.6

8.61

7.18

iu/ml

0.30

539

(3045716) Anion gap in Serum or Plasma by calculation

873

1.09

0.33

2.2

3.0

9.22

10.79

mmol/l

5.09

861

(3012501) Base excess in Blood by calculation

168

1579

1.07

0.33

3.9

4.5

2.46

2.62

mmol/l

0.35

131

1079

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

144

0.76

0.33

3.2

2.0

1.49

1.03

ug/l

0.41

135

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.30

0.33

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

577

1.11

0.33

1.3

1.4

1096.36

301.64

titre

0.67

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

133

1424

0.93

0.32

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

242

0.83

0.32

1.3

1.5

5.67

17.07

umol/l

1.57

160

(3027315) Oxygen [Partial pressure] in Blood

169

1591

1.06

0.32

3.9

4.5

8.32

8.43

kpa

0.37

164

1557

(3014148) Varicella zoster virus Ab [Titer] in Serum

434

0.87

0.32

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

176

0.80

0.32

2.2

2.4

5.00

241.36

ug/l

0.82

176

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

717

0.91

0.31

1.3

1.2

59.26

67.55

u/l

0.92

621

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

142

0.77

0.30

1.0

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

371

1.13

0.30

2.2

1.7

84.33

92.07

umol/l

0.87

371

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

153

0.78

0.30

1.3

1.4

1.16

1.17

mmol/l

0.16

153

(44806420) Estimation of glomerular filtration rate

463

0.88

0.30

2.8

2.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

431

0.88

0.30

2.7

4.0

—

(4146454) Self-monitoring of blood glucose

870

0.92

0.30

2.5

2.7

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

287

1.15

0.30

1.1

—

(3025941) Bacteria identified in Stool by Culture

298

2859

1.04

0.29

1.3

—

(3000034) Microalbumin [Mass/volume] in Urine

619

0.90

0.29

3.2

3.1

35.35

44.20

mg/l

0.24

459

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

184

0.81

0.28

1.3

42.60

36.37

—

122

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

166

1752

0.95

0.28

1.5

1.14

1.17

g/l

0.78

158

1666

(3008116) Ketones [Moles/volume] in Urine by Test strip

158

1.20

0.28

1.3

1.5

0.16

0.34

mmol/l

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.29

0.28

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.27

0.27

1.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1030

0.93

0.27

1.1

1.2

—

0.97

—

(3036489) Thrombin time

218

2280

0.95

0.27

1.8

1.9

21.52

21.50

0.01

200

2074

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.19

0.26

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

541

0.91

0.26

1.3

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.28

0.26

1.3

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

409

3964

1.03

0.26

1.2

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

686

0.92

0.25

1.4

1.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

488

0.90

0.25

1.3

1.8

87.17

115.00

ng/l

2.22

488

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

171

1629

1.05

0.24

1.7

1.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1021

10030

1.02

0.24

3.8

5.9

1.00

1.04

mmol/l

5.84

934

9300

(4094501) Cardiovascular stress test using bicycle ergometer

176

1679

1.05

0.24

1.1

—

(44790048) Parainfluenza type 2 nucleic acid detection

880

0.93

0.24

1.2

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

880

0.93

0.24

1.2

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

880

0.93

0.24

1.2

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

880

0.93

0.24

1.2

1.4

—

(3037121) Protein [Mass/volume] in Urine

258

2484

1.04

0.24

2.3

3.1

208.30

424.05

mg/l

4.22

1102

(44813793) Dust mix specific IgE antibody measurement

303

1.12

0.23

1.0

1.1

—

(3049717) Cytology report of Urine Cyto stain

359

3481

1.03

0.23

2.2

2.9

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

671

0.92

0.23

1.5

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

125

1184

1.06

0.23

1.4

0.83

0.85

nmol/l

0.10

101

978

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.25

0.22

1.0

—

(3042936) Bacteria identified in Isolate by Culture

1036

10197

1.02

0.21

2.0

2.1

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

1396.36

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

2.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

101

0.79

0.21

17.4

13.7

4.39

5.11

mmol/l

—

101

(3004775) Volume in Urine collected for unspecified duration

585

0.92

0.21

2.0

2.2

544.71

656.68

1.40

363

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.16

0.21

1.0

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.16

0.21

1.0

1.1

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

643

1.07

0.21

1.8

1.5

24.21

28.02

0.41

403

(3020961) Endomysium IgA Ab [Titer] in Serum

209

2170

0.96

0.21

1.1

494.43

201.17

titre

—

(36660577) Edoxaban [Mass/volume] in Platelet poor plasma by Chromogenic method

0.00

0.21

0.0

1.7

—

93.13

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.24

0.20

1.3

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

821

0.94

0.20

1.3

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

123

0.81

0.20

1.3

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.3

—

25.07

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

1.1

—

0.21

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

12.36

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.01

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.11

—

(3019832) Treponema pallidum Ab [Presence] in Serum

175

1680

1.04

0.20

1.2

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

490

0.92

0.20

1.2

1.1

3.57

3.21

eliau/ml

0.07

135

(21491868) Cryoglobulin [Mass/volume] in Serum

229

0.87

0.20

1.1

1.2

—

0.22

g/l

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

354

0.90

0.19

4.0

3.0

218.88

207.35

u/l

0.32

347

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

327

1.10

0.19

1.1

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

457

0.92

0.18

1.2

70.00

134.32

titre

1.07

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.13

0.18

3.0

1.4

—

(3025130) Human papilloma virus identified in Specimen

347

1.10

0.18

1.7

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.21

0.18

1.1

1.4

—

(3016750) Collection duration of Urine

404

0.92

0.18

1.7

2.1

503.54

495.63

min

0.16

283

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1985

19673

1.01

0.18

2.9

3.3

31.15

36.75

u/l

2.70

1847

18397

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

300

0.90

0.18

1.2

1.5

0.19

0.20

nmol/l

0.10

212

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.17

0.17

1.0

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

414

0.92

0.17

1.3

1.2

100.90

92.60

u/l

0.16

344

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.15

0.17

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.15

0.17

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.15

0.17

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

142

0.84

0.17

1.3

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

500

4902

1.02

0.17

6.5

8.9

24.72

24.20

mmol/l

3.20

485

4773

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.72

0.16

3.0

2.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

330

1.09

0.16

1.1

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1040

10272

1.01

0.16

1.4

1.5

2.43

2.71

g/l

2.50

543

5906

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

118

1131

1.04

0.16

1.7

1.9

187.34

197.58

pmol/l

0.66

113

1050

(3035637) Corticotropin [Mass/volume] in Plasma

789

1.05

0.15

1.4

1.6

53.29

28.68

ng/l

0.72

789

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

380

1.08

0.15

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

380

1.08

0.15

1.3

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

171

0.88

0.14

2.1

1.8

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

211

2054

1.03

0.13

1.1

1.2

1.75

1.05

u/ml

0.28

184

(4133840) Spirometry

122

1.15

0.13

1.1

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

170

0.88

0.13

2.5

2.4

6.60

7.90

mmol/l

—

110

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

128

0.86

0.13

1.0

1.3

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

210

0.90

0.12

1.0

1.3

6.83

12.17

pmol/l

—

(1002224) Polysomnography panel

156

1605

0.97

0.12

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

191

1.10

0.11

1.6

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

343

0.93

0.11

1.6

1.7

39.49

39.44

g/l

0.02

343

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

702

6941

1.01

0.11

1.9

2.2

0.20

g/l

0.09

645

6433

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

202

1974

1.02

0.11

1.6

37.56

28.83

u/ml

0.41

321

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

147

1430

1.03

0.11

1.5

1.8

48.76

45.26

nmol/l

1.10

142

1369

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

196

2005

0.98

0.10

1.5

1.4

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

663

1.04

0.10

2.3

2.2

538.84

960.60

2.44

655

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

616

0.96

0.10

1.1

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

402

0.94

0.10

1.3

1.2

22.03

25.83

u/l

0.22

327

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

114

0.88

0.09

1.1

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.06

0.09

1.2

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

258

0.93

0.09

1.0

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

502

0.96

0.08

3.3

2.9

21.75

32.56

mg/l

2.39

392

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

134

0.90

0.08

1.1

1.4

8.17

13.49

mm/h

1.04

134

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

107

1.12

0.08

1.2

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

568

1.04

0.08

1.3

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.04

0.08

2.9

4.4

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

127

1.10

0.07

1.6

1.4

3.35

2.62

umol/l

0.70

109

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

895

0.97

0.07

1.3

1.4

—

(3026726) Creatinine [Moles/volume] in Specimen

0.81

0.07

2.5

167.33

482.46

umol/l

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

296

0.95

0.07

7.0

6.6

4.94

175.18

ug/l

0.96

183

(3039162) Centromere protein B Ab [Units/volume] in Serum

649

1.03

0.07

1.2

27.86

53.19

u/ml

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.82

0.07

1.0

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

255

0.94

0.07

1.3

1.2

42.51

40.43

g/l

0.46

123

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.87

0.06

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

216

1.06

0.06

1.1

1519.09

1598.95

miu/ml

0.11

216

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.86

0.06

1.1

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

0.84

0.06

1.3

1.2

6.71

7.98

mg/l

—

(3019230) Fractional oxyhemoglobin in Venous blood

166

1632

1.02

0.06

2.0

2.3

60.90

60.75

0.03

166

1626

(3024522) Salmonella sp identified in Specimen by Organism specific culture

902

0.98

0.06

1.3

1.4

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

101

0.89

0.06

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

197

1.07

0.06

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

197

1.07

0.06

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

197

1.07

0.06

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

197

1.07

0.06

1.0

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5885

58905

0.99

0.06

11.9

13.7

19.67

25.34

u/l

139.91

5588

56806

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

537

5409

0.99

0.05

2.9

2.8

65.65

60.33

ml/min/173m2

2.38

222

2373

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

141

0.92

0.05

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

869

0.98

0.05

1.2

1.4

—

(40768797) Stomach Pathology biopsy report

904

8996

1.01

0.05

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

938

0.98

0.05

1.3

1.4

9.65

10.72

u/l

0.50

746

(3022313) Gas panel - Capillary blood

358

3608

0.99

0.04

3.6

4.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

866

0.98

0.04

1.2

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

483

0.97

0.04

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

275

2773

0.99

0.04

1.9

3.1

2.32

4.75

ratio

1.08

165

1618

(3036071) Salmonella sp Ab [Titer] in Serum

129

0.93

0.03

1.2

1.1

—

(3037756) Immunofixation for Serum or Plasma

188

1898

0.99

0.03

1.4

1.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

864

0.98

0.03

1.2

1.4

—

(3022806) Fractional oxyhemoglobin in Capillary blood

914

0.98

0.03

2.2

1.9

89.55

89.03

0.43

903

(3025018) Bordetella pertussis Ab [Titer] in Serum

270

1.04

0.03

1.3

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

108

0.93

0.03

1.1

1.2

—

(4015189) Microbial culture of sputum

211

1.04

0.03

1.9

2.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

310

3083

1.01

0.02

2.0

3.2

36.08

53.06

mg/l

1.96

263

2614

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

636

6342

1.00

0.02

2.5

37.87

39.91

u/l

0.14

526

5325

(3034860) Kappa light chains.free [Mass/volume] in Serum

310

3086

1.00

0.02

2.0

3.2

45.41

76.48

mg/l

1.06

264

2619

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

138

1391

0.99

0.02

1.2

1.4

—

(3006462) Nitrate [Presence] in Urine

308

0.97

0.02

4.0

3.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

174

1751

0.99

0.01

2.1

2.3

97.60

102.64

ug/min

0.08

105

989

(3051101) Glucose [Moles/volume] in Cord blood

147

0.95

0.01

4.6

6.6

8.91

8.42

mmol/l

0.24

147

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

161

1600

1.01

0.01

1.2

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

487

0.99

0.01

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.06

0.01

1.1

—

16.14

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

146

0.96

0.00

1.1

—

25.32

—

(3028433) Virus identified in Specimen by Culture

206

0.97

0.00

1.1

—

(4211845) Urine protein measurement

334

1.02

0.00

3.7

3.6

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

816

0.99

0.00

1.0

1.1

35.69

527.10

iu/ml

0.87

154

(37208534) Antinuclear antibody arbitrary concentration in serum

160

1.00

0.00

1.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

139

1389

1.00

0.00

1.3

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

413

0.99

0.00

5.1

5.5

60.72

62.82

u/ml

0.02

125

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

914

1.00

0.00

1.3

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

566

1.01

0.00

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

156

1562

1.00

0.00

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

346

1.01

0.00

2.5

3.6

1.03

1.26

0.61

346

(3014891) Appearance of Pleural fluid

127

1.02

0.00

1.6

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

362

0.99

0.00

1.8

1.3

1.07

1.18

nmol/l

0.28

258

(3003740) Influenza virus B Ag [Presence] in Specimen

487

1.01

0.00

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

208

1.01

0.00

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

404

0.99

0.00

1.2

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

404

0.99

0.00

1.2

1.4

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

227.74

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

0.97

0.00

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

-0.00

0.0

1.0

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

298.83

—

(3050794) Legionella sp Ab [Presence] in Serum

0.85

-0.00

1.2

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

-0.00

0.0

2.4

—

19.08

—

(3001556) Androgen free Index in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3021374) Sirolimus [Mass/volume] in Blood

0.00

-0.00

0.0

7.0

—

7.20

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

3618.17

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

31.00

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.2

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.3

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.00

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.88

-0.00

1.3

1.7

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3038413) Eosinophils/Leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

5.8

—

14.00

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

-0.00

0.0

1.6

—

0.42

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.89

-0.00

1.2

—

mmol/l

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.90

-0.00

1.0

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: G6_PARKINSON_INCLAVO – Parkinson's disease, including avohilmo

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Parkinson's disease, including avohilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Case counts by code for Parkinson's disease, including avohilmo (G6_PARKINSON_INCLAVO)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints